HOMCOS(prot_sch_conbars.cgi):

		Contact Molecules for Homologous Proteins
[Full Bars]	[SiteTable]	Summary Bars[0.0 %]	[Back to Search Page]	[Back to HOMCOS]
[SupCon3D]	[help]	seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100]	[show] [download] [help]

PID

QueryLength

Homolgous Sequence in PDB

UniProt Query

TITLE

783141

424

500

P47901(V1BR_HUMAN)

RecName: Full=Vasopressin V1b receptor ; Short=V1bR;AltName: Full=AVPR V1b;AltName: Full=AVPR V3;AltName: Full=Antidiuretic hormone receptor 1b;AltName: Full=Vasopressin V3 receptor;

QUERYSEQ

MDSGPLWDANPTPRGTLSAPNATTPWLGRDEELAKVEIGVLATVLVLATGGNLAVLLTLGQLGRKRSRMHLFVLHLALTDLAVALFQVLPQLLWDITYRFQGPDLLCRAVKYLQVLSMFASTYMLLAMTLDRYLAVCHPLRSLQQPGQST
YLLIAAPWLLAAIFSLPQVFIFSLREVIQGSGVLDCWADFGFPWGPRAYLTWTTLAIFVLPVTMLTACYSLICHEICKNLKVKTQAWRVGGGGWRTWDRPSPSTLAATTRGLPSRVSSINTISRAKIRTVKMTFVIVLAYIACWAPFFSV
QMWSVWDKNAPDEDSTNVAFTISMLLGNLNSCCNPWIYMGFNSHLLPRPLRHLACCGGPQPRMRRRLSDGSLSSRHTTLLTRSSCPATLSLSLSLTLSGRPRPEESPRDLELADGEGTAETIIF

[BLAST file for PDB] (plain) (bar) (multiple alignment) [BLAST for UniProt: (plain) (bar) (multiple alignment) (PSSM file) ]

UniProt Feature Tables [P47901(V1BR_HUMAN)]

424
	region	name	description
	1-424	CHAIN	/note="Vasopressin V1b receptor" /id="PRO_0000070203"
	1-35	TOPO_DOM	/note="Extracellular"
	36-59	TRANSMEM	/note="Helical; Name=1"
	60-71	TOPO_DOM	/note="Cytoplasmic"
	72-93	TRANSMEM	/note="Helical; Name=2"
	94-108	TOPO_DOM	/note="Extracellular"
	109-130	TRANSMEM	/note="Helical; Name=3"
	131-151	TOPO_DOM	/note="Cytoplasmic"
	152-173	TRANSMEM	/note="Helical; Name=4"
	174-201	TOPO_DOM	/note="Extracellular"
	202-222	TRANSMEM	/note="Helical; Name=5"
	223-283	TOPO_DOM	/note="Cytoplasmic"
	284-303	TRANSMEM	/note="Helical; Name=6"
	304-321	TOPO_DOM	/note="Extracellular"
	322-341	TRANSMEM	/note="Helical; Name=7"
	342-424	TOPO_DOM	/note="Cytoplasmic"
	1-22	REGION	/note="Disordered"
	398-417	REGION	/note="Disordered"
	1-424	DISORDER	predicted by DISOPRED

MONOMER

424

pdb_id a¹ identity[%]² description

7ryc B 63.9 OXYR_HUMAN Oxytocin receptor

8wz2 F 27.8 QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor

7xrr A 28.3 OX2R_HUMAN Orexin receptor type 2

4yay A 25.6 C562_ECOLX AGTR1_HUMAN Soluble cytochrome b562,Type-1 angiotensin II receptor

2ped B 21.3 OPSD_BOVIN Rhodopsin

1.a¹:asym_id for the homologue. 2.identity[%]²:sequence identity between the query and the homologue.

HETERO

424 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

7qvm[1] A A0A1W2PS82_HUMAN B3KP89_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. E 81.8
/64.3 11
/11 OXYR_HUMAN Oxytocin receptor

7qvm[1] D NEU1_HUMAN Oxytocin[10 aa] E 70.0
/64.3 20
/20 OXYR_HUMAN Oxytocin receptor

7ryc[1] A NEU1_HUMAN Oxytocin[10 aa] B 71.4
/63.9 21
/21 OXYR_HUMAN Oxytocin receptor

7bb6[2] E arginine-vasopressin[10 aa] A 80.0
/55.5 10
/12 V2R_HUMAN Vasopressin V2 receptor

7dw9[1] G CYS-TYR-PHE-GLN-ASN-CYS-PRO-ARG-GLY-NH2[10 aa] A 69.2
/52.3 26
/27 V2R_HUMAN Vasopressin V2 receptor

7kh0[1] D NEU2_HUMAN Arg-vasopressin[10 aa] A 66.7
/54.7 24
/24 V2R_HUMAN Vasopressin V2 receptor

7r0c[1] B AVP[10 aa] A 62.5
/53.8 16
/16 V2R_HUMAN Vasopressin V2 receptor

7dw9[1] B Guanine nucleotide-binding protein G(s) subunit al.. A 53.3
/52.3 15
/18 V2R_HUMAN Vasopressin V2 receptor

7xjh[2] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. E 87.5
/36.6 8
/23 ADRB3_CANLF Beta-3 adrenergic receptor

7xwo[1] D G324[229 aa] A 55.6
/36.4 9
/15 C562_ECOLX NK2R_HUMAN Soluble cytochrome b562,Substance-K receptor

7xwo[1] F HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2[11 aa].. A 16.7
/36.4 6
/17 C562_ECOLX NK2R_HUMAN Soluble cytochrome b562,Substance-K receptor

7f9y[2] A Engineered G-alpha-q subunit[228 aa] F 42.9
/35.3 14
/18 Soluble cytochrome b562

7f9y[1] C GHRL_HUMAN Ghrelin-28[15 aa] F 33.3
/35.3 3
/17 Soluble cytochrome b562

7w2z[1] F GHRL_HUMAN Appetite-regulating hormone[16 aa] B 45.5
/35.2 11
/26 GHSR_HUMAN Growth hormone secretagogue receptor type 1

5xjm[2] D Sar1, Ile8-angiotensin II[8 aa] A 35.3
/33.8 17
/22 AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome ..

6do1[2] H Angiotensin-like peptide S1I8[8 aa] A 28.6
/26.9 7
/26 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome ..

7c6a[1] A IgG Light Chain[211 aa] C 50.0
/34.6 4
/7 AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome ..

7na7[1] F GHRL_HUMAN Ghrelin-27[12 aa] E 33.3
/34.6 12
/25 GHSR_HUMAN Growth hormone secretagogue receptor type 1

5xjm[2] B FabH[220 aa] A 33.3
/33.8 12
/18 AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome ..

5xjm[2] C FabL[212 aa] A 0.0
/33.8 2
/5 AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome ..

6jod[1] C C562_ECOLX C562_ECOLX Soluble cytochrome b562,Soluble cytochrome b562[59.. A 0.0
/34.3 3
/4 AGTR2_HUMAN Type-2 angiotensin II receptor

6wha[1] B G subunit q (Gi2-mini-Gq chimeric)[211 aa] A 37.5
/30.3 16
/17 C562_ECOLX 5HT2A_HUMAN Soluble cytochrome b562,5-hydroxytryptamine recept..

7dh5[3] A GNAS2_HUMAN GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. E 75.0
/36.6 8
/20 ADRB3_CANLF Beta-3 adrenergic receptor

7l1u[2] A Engineered Guanine nucleotide-binding protein subu.. E 46.2
/29.2 13
/16 Q548Y0_HUMAN Hypocretin receptor type 2

7mby[5] E GNAI1_HUMAN GNAS2_HUMAN GNAS2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. D 40.0
/33.7 15
/16 CCKAR_HUMAN Cholecystokinin receptor type A

7p00[2] D GNAI1_HUMAN A0A590UJY2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 35.7
/23.6 14
/22 NK1R_HUMAN Substance-P receptor

7ran[3] B G protein subunit q (Gi2-mini-Gq chimera)[232 aa] A 40.0
/28.4 15
/15 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A

7ryc[1] C Guanine nucleotide-binding protein G(I)/G(S)/G(O) .. B 75.0
/63.9 12
/12 OXYR_HUMAN Oxytocin receptor

7sr8[1] A a modified Guanine nucleotide-binding protein G(q).. E 50.0
/29.2 14
/19 Q548Y0_HUMAN Hypocretin receptor type 2

7srr[1] A G protein subunit q (Gi2-mini-Gq chimera)[225 aa] E 36.4
/29.8 11
/19 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B

7x1u[3] C mini-G alpha q prtoein[221 aa] B 37.5
/33.7 8
/19 TRFR_HUMAN Thyrotropin-releasing hormone receptor

7y26[2] B Engineered Guanine nucleotide-binding protein G(q).. E 44.4
/27.8 9
/13 SSR2_HUMAN Somatostatin receptor type 2

8zh8[1] E GBG2_HUMAN GNAI2_HUMAN GNAS1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) .. A 27.3
/27.8 22
/23 QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor

7mbx[3] E CCKN_HUMAN Cholecystokinin-8[9 aa] F 11.1
/33.7 18
/27 CCKAR_HUMAN Cholecystokinin receptor type A

7xou[1] A CCK-8[9 aa] F 5.3
/33.7 19
/25 CCKAR_HUMAN Cholecystokinin receptor type A

8ia7[1] F CCK-8[9 aa] A 14.3
/34.1 21
/21 GASR_HUMAN Gastrin/cholecystokinin type B receptor

7xow[2] E GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. A 42.9
/34.1 14
/16 GASR_HUMAN Gastrin/cholecystokinin type B receptor

7xow[1] F GAST_HUMAN Gastrin[8 aa] A 10.5
/34.1 19
/19 GASR_HUMAN Gastrin/cholecystokinin type B receptor

7na7[2] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 40.0
/34.6 15
/18 GHSR_HUMAN Growth hormone secretagogue receptor type 1

6ko5[1] B Fab7881 Heavy Chain[218 aa] A 20.0
/33.8 10
/10 C562_ECOLX GHSR_HUMAN Chimera of Soluble cytochrome b562 and Growth horm..

6ko5[1] C Fab7881 Light Chain[219 aa] A 0.0
/33.8 2
/2 C562_ECOLX GHSR_HUMAN Chimera of Soluble cytochrome b562 and Growth horm..

7wkd[1] F TRH[3 aa] E 25.0
/33.7 4
/17 TRFR_HUMAN Thyrotropin-releasing hormone receptor

7ezh[3] F Cholecystokinin-8[9 aa] C 17.6
/33.7 17
/26 CCKAR_HUMAN Cholecystokinin receptor type A

7ezk[1] A GNAI1_HUMAN GNAS2_HUMAN GNAI1_HUMAN GNAS2_HUMAN Chimera of Guanine nucleotide-binding protein G(i).. C 55.0
/33.7 20
/23 CCKAR_HUMAN Cholecystokinin receptor type A

7ezm[1] A GNAI1_HUMAN GNAQ_HUMAN fusion protein of Guanine nucleotide-binding prote.. C 47.4
/33.7 19
/29 CCKAR_HUMAN Cholecystokinin receptor type A

7mbx[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. F 64.3
/33.7 14
/19 CCKAR_HUMAN Cholecystokinin receptor type A

8th4[1] D AT118-L Nanobody[112 aa] A 100.0
/33.6 1
/23 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor Soluble cytochrome ..

7wq3[2] F GALA_HUMAN Galanin[16 aa] A 25.0
/28.2 12
/18 GALR1_HUMAN Galanin receptor type 1

7xbd[1] F GALA_HUMAN Galanin[16 aa] A 25.0
/33.0 16
/17 GALR2_HUMAN Galanin receptor type 2

7xjl[1] A spexin[14 aa] F 22.2
/33.5 18
/19 GALR2_HUMAN Galanin receptor type 2

7f8v[1] A GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 45.5
/33.3 11
/16 GASR_HUMAN Gastrin/cholecystokinin type B receptor

7f8v[2] D Gastrin-17[17 aa] E 11.1
/33.3 27
/30 GASR_HUMAN Gastrin/cholecystokinin type B receptor

7f8w[1] A GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. F 31.2
/33.3 16
/21 GASR_HUMAN Gastrin/cholecystokinin type B receptor

7wq4[1] B GALA_HUMAN Galanin[13 aa] A 27.3
/33.2 22
/22 GALR2_HUMAN Galanin receptor type 2

7wq4[1] C Engineered Guanine nucleotide-binding protein G(q).. A 45.0
/33.2 20
/21 GALR2_HUMAN Galanin receptor type 2

7f8x[1] B ASP-SMF-NLE-GLY-TRP-NLE-OEM-MEA-NH2 (NN9056)[9 aa].. A 10.5
/33.2 19
/27 CCKAR_HUMAN ENLYS_BPT4 CCKAR_HUMAN Cholecystokinin receptor type A,Endolysin

3sn6[1] B GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. D 50.0
/26.1 2
/2 ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor

6ni3[1] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. D 100.0
/26.1 1
/1 A0A097J809_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor chimera

6oik[10] C GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 0.0
/29.8 1
/1 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Muscarinic ac..

6omm[14] D GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 50.0
/29.8 2
/2 FPR2_HUMAN N-formyl peptide receptor 2

6osa[1] D GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 0.0
/24.4 2
/2 NTR1_HUMAN Neurotensin receptor type 1

6oya[1] B GBB1_BOVIN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 0.0
/21.0 1
/1 OPSD_BOVIN Rhodopsin

7bb6[2] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 50.0
/55.5 4
/4 V2R_HUMAN Vasopressin V2 receptor

7dh5[4] B GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 50.0
/36.6 2
/2 ADRB3_CANLF Beta-3 adrenergic receptor

7f1r[1] C GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 100.0
/28.6 1
/1 CCL5_HUMAN CCR5_HUMAN C-C motif chemokine 5,C-C chemokine receptor type ..

7f8v[1] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 0.0
/33.3 1
/1 GASR_HUMAN Gastrin/cholecystokinin type B receptor

7f9y[2] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. F 0.0
/35.3 1
/1 Soluble cytochrome b562

7jjo[4] A GBB1_BOVIN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 50.0
/31.5 2
/2 Beta1-Adrenergic Receptor

7mbx[6] B GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. F 0.0
/33.7 1
/1 CCKAR_HUMAN Cholecystokinin receptor type A

7sr8[2] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 0.0
/29.2 2
/2 Q548Y0_HUMAN Hypocretin receptor type 2

7t2g[1] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. D 0.0
/28.5 1
/1 C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor

7t6s[3] B GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 50.0
/29.8 2
/2 FPR2_HUMAN N-formyl peptide receptor 2

7w0m[3] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. D 100.0
/30.1 1
/2 C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor

7w55[2] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. F 0.0
/26.7 1
/1 Neuromedin-U receptor 2

7wj5[1] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 0.0
/27.2 2
/2 C562_ECOLX SSR2_HUMAN Soluble cytochrome b562,Somatostatin receptor type..

7wq3[3] C GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 100.0
/28.2 1
/2 GALR1_HUMAN Galanin receptor type 1

7wq4[1] D GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 0.0
/33.2 1
/1 GALR2_HUMAN Galanin receptor type 2

7wvw[2] D GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. B 100.0
/30.9 1
/1 C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor ..

7x9b[1] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. D 0.0
/26.1 1
/1 NPY2R_HUMAN Neuropeptide Y receptor type 2

7xav[1] C GBB1_BOVIN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 0.0
/27.8 1
/1 SSR2_HUMAN Somatostatin receptor type 2,LargeBit

7y89[2] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 0.0
/31.0 1
/1 GPR17_HUMAN Uracil nucleotide/cysteinyl leukotriene receptor

7yon[3] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 0.0
/26.8 1
/1 NPY2R_HUMAN Neuropeptide Y receptor type 2

8ge1[5] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. D 100.0
/25.3 1
/1 ADRB2_HUMAN Beta-2 adrenergic receptor

8ge3[2] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. D 0.0
/25.4 1
/1 ADRB2_HUMAN Beta-2 adrenergic receptor

8i95[2] B GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. E 0.0
/32.9 1
/1 C3AR_HUMAN C3a anaphylatoxin chemotactic receptor

8ia8[1] D GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. B 0.0
/31.0 1
/3 C3AR_HUMAN C3a anaphylatoxin chemotactic receptor

8uwl[2] C GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 0.0
/28.2 1
/1 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A

8wz2[1] B GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. F 0.0
/27.8 1
/1 QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor

8xip[1] C GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 0.0
/32.6 1
/1 SSR1_HUMAN Somatostatin receptor type 1

8zh8[1] C GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. A 0.0
/27.8 1
/1 QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor

9bkj[1] C CCKN_HUMAN Cholecystokinin-8[8 aa] D 11.1
/33.2 18
/26 CCKAR_HUMAN Cholecystokinin receptor type A

7y24[2] E Octreotide[8 aa] F 33.3
/28.2 18
/18 SSR2_HUMAN Somatostatin receptor type 2

8x8n[1] F octreotide[8 aa] E 18.2
/32.9 11
/11 SSR5_HUMAN Somatostatin receptor type 5

8x8l[1] A Guanine nucleotide-binding protein G(i) subunit al.. F 60.0
/32.9 15
/18 SSR5_HUMAN Somatostatin receptor type 5

8x8l[1] C CORT_HUMAN Cortistatin[12 aa] F 24.0
/32.9 25
/25 SSR5_HUMAN Somatostatin receptor type 5

8x8n[1] A Guanine nucleotide-binding protein G(i) subunit al.. E 55.6
/32.9 9
/11 SSR5_HUMAN Somatostatin receptor type 5

7w2z[1] A A0A1W2PS82_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. B 42.9
/35.2 14
/16 GHSR_HUMAN Growth hormone secretagogue receptor type 1

7xjj[1] A A0A1W2PRJ7_HUMAN A0A1W2PP38_HUMAN GNAO_HUMAN G protein subunit alpha o1,Guanine nucleotide-bind.. D 33.3
/29.2 9
/21 GALR1_HUMAN Galanin receptor type 1

7y24[1] A GNAO_HUMAN GNAO_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. F 54.5
/28.2 11
/15 SSR2_HUMAN Somatostatin receptor type 2

8i95[1] A GNAO_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. E 37.5
/32.9 8
/17 C3AR_HUMAN C3a anaphylatoxin chemotactic receptor

8i95[2] F EP54 ligand[9 aa] E 36.4
/32.9 11
/24 C3AR_HUMAN C3a anaphylatoxin chemotactic receptor

8i9a[1] A Guanine nucleotide-binding protein G(q) subunit al.. E 36.4
/32.9 11
/17 C3AR_HUMAN C3a anaphylatoxin chemotactic receptor

8xio[2] B G-alpha-i[236 aa] A 58.8
/32.6 17
/19 SSR1_HUMAN Somatostatin receptor type 1

8xip[1] F 004-DTR-LYS-TY5-PHE-A1D5E[6 aa] A 38.9
/32.6 18
/20 SSR1_HUMAN Somatostatin receptor type 1

4rwa[4] D bifunctional peptide[5 aa] A 25.0
/33.3 12
/12 C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor..

8ef6[1] G GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. F 36.8
/28.4 19
/19 OPRM_HUMAN Mu-type opioid receptor

8f7q[1] I GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. G 25.0
/28.4 16
/16 OPRM_HUMAN Mu-type opioid receptor

8f7s[1] H GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. F 40.0
/32.2 15
/15 OPRD_HUMAN Delta-type opioid receptor

8f7s[2] B DA2D_PHYBI deltorphin[8 aa] A 26.3
/32.2 19
/19 OPRD_HUMAN Delta-type opioid receptor

8f7s[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 35.0
/32.2 20
/21 OPRD_HUMAN Delta-type opioid receptor

6h7j[2] C Camelid antibody fragment Nb80[119 aa] B 29.2
/32.0 24
/27 ADRB1_MELGA Beta-1 adrenergic receptor

6ibl[2] B Camelid antibody fragment Nb80[119 aa] A 34.8
/32.2 23
/26 THIO_ECOLI ADRB1_MELGA Thioredoxin 1,Beta-1 adrenergic receptor

7x1u[2] F Endogenous Peptide Agonist TRH[4 aa] B 20.0
/33.7 5
/18 TRFR_HUMAN Thyrotropin-releasing hormone receptor

7xw9[1] B Guanine nucleotide-binding protein G(q) subunit al.. A 33.3
/31.8 9
/23 TRFR_HUMAN Thyrotropin-releasing hormone receptor

6pt2[2] C Peptide agonist KGCHM07[5 aa] A 30.0
/31.5 20
/21 Delta opioid receptor

7s0g[1] C GNAI1_RAT GNAS2_BOVIN Guanine nucleotide-binding protein G(i) subunit al.. A 46.7
/31.6 15
/17 Beta1-Adrenergic Receptor

7jjo[3] C GNAS2_BOVIN Guanine nucleotide-binding protein G(s) subunit al.. E 43.8
/31.5 16
/18 Beta1-Adrenergic Receptor

6h7j[10] A THIO_ECOLI Thioredoxin 1[106 aa] B 100.0
/32.0 2
/3 ADRB1_MELGA Beta-1 adrenergic receptor

7s0f[1] C GNAI1_RAT Guanine nucleotide-binding protein G(i) subunit al.. A 37.5
/31.3 16
/17 Beta1-Adrenergic Receptor

7xmt[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 44.4
/31.2 18
/20 SSR4_HUMAN Somatostatin receptor type 4

4mqs[2] B Nanobody 9-8[121 aa] A 28.6
/29.8 7
/12 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2

7y89[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 33.3
/31.0 15
/21 GPR17_HUMAN Uracil nucleotide/cysteinyl leukotriene receptor

7f1q[2] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 50.0
/28.2 18
/22 CCL3_HUMAN CCR5_HUMAN C-C motif chemokine 3,C-C chemokine receptor type ..

7f1s[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 46.7
/28.8 15
/19 CCR5_HUMAN C-C chemokine receptor type 5

7vh0[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 26.7
/31.6 15
/15 MTR1B_HUMAN Melatonin receptor type 1B

7wj5[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 46.7
/27.2 15
/17 C562_ECOLX SSR2_HUMAN Soluble cytochrome b562,Somatostatin receptor type..

7x9a[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 27.8
/24.5 18
/18 NPY1R_HUMAN Neuropeptide Y receptor type 1

7yoo[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 40.0
/26.8 15
/16 NPY2R_HUMAN Neuropeptide Y receptor type 2

8dzp[2] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 44.4
/28.9 9
/23 OPRK_HUMAN Kappa-type opioid receptor

8ia8[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. B 42.9
/31.0 7
/15 C3AR_HUMAN C3a anaphylatoxin chemotactic receptor

8ia8[1] A ALA-SER-LYS-LEU-GLY-LEU-ALA-ARG[8 aa] B 25.0
/31.0 12
/19 C3AR_HUMAN C3a anaphylatoxin chemotactic receptor

7wvw[1] A FME-TYR-PHE-ILE-ASN-ILE-LEU-THE-LEU[7 aa] B 29.4
/30.9 17
/21 C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor ..

7wvx[1] A HUNIN_HUMAN Humanin[15 aa] B 35.0
/30.9 20
/23 C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor ..

7wvx[1] C GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. B 29.4
/30.9 17
/17 C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor ..

8dzr[1] B G alpha gustducin protein[205 aa] A 50.0
/30.8 10
/21 OPRK_HUMAN Kappa-type opioid receptor

7wj5[1] F Somatostatin-14 (SST-14)[12 aa] E 40.9
/27.2 22
/22 C562_ECOLX SSR2_HUMAN Soluble cytochrome b562,Somatostatin receptor type..

7xat[1] F SMS_HUMAN Somatostatin-14[12 aa] A 35.0
/27.2 20
/20 SSR2_HUMAN Somatostatin receptor type 2,LargeBit

7xms[1] F SMS_HUMAN Somatostatin-14[12 aa] A 21.1
/30.8 19
/19 SSR4_HUMAN Somatostatin receptor type 4

7xms[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 47.6
/30.8 21
/21 SSR4_HUMAN Somatostatin receptor type 4

7t6v[1] F Synthetic peptide[5 aa] A 33.3
/29.8 15
/17 FPR2_HUMAN N-formyl peptide receptor 2

7wvv[1] A FME-LEU-PHE-ILE-ILE[5 aa] B 25.0
/30.7 16
/20 C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor ..

7wvv[3] C GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. B 41.2
/30.7 17
/19 C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor ..

7wvy[1] A B4DMD5_HUMAN Amyloid-beta A4 protein[16 aa] B 37.5
/30.7 24
/28 C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor ..

7sqo[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 66.7
/30.4 6
/13 OX2R_HUMAN Orexin receptor type 2

8wss[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. F 33.3
/30.2 18
/21 MCHR1_HUMAN Melanin-concentrating hormone receptor 1

8wss[1] E MCH_HUMAN Pro-MCH[17 aa] F 26.1
/30.2 23
/23 MCHR1_HUMAN Melanin-concentrating hormone receptor 1

7w0l[2] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 41.7
/30.1 12
/13 C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor

7w0m[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. D 33.3
/30.1 12
/14 C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor

7w0n[4] H ELA_HUMAN Apelin receptor early endogenous ligand[15 aa] D 23.5
/30.1 17
/18 C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor

7w0o[2] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 30.0
/30.1 10
/12 C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor

8f7x[1] B PNOC_HUMAN Nociceptin[14 aa] A 33.3
/30.1 21
/22 OPRX_HUMAN Nociceptin receptor

8f7x[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 21.1
/30.1 19
/19 OPRX_HUMAN Nociceptin receptor

6ni3[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 33.3
/26.1 18
/20 A0A097J809_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor chimera

7bb6[2] C GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. A 64.3
/55.5 14
/17 V2R_HUMAN Vasopressin V2 receptor

7kh0[1] C GNAI3_HUMAN GNAS2-2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 66.7
/54.7 18
/20 V2R_HUMAN Vasopressin V2 receptor

7xou[2] B GNAS2_HUMAN Isoform Gnas-2 of Guanine nucleotide-binding prote.. F 50.0
/33.7 16
/20 CCKAR_HUMAN Cholecystokinin receptor type A

8gdz[17] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 29.4
/25.4 17
/19 ADRB2_HUMAN Beta-2 adrenergic receptor

8pok[1] B GNAS2_HUMAN Isoform Gnas-2 of Guanine nucleotide-binding prote.. A 61.5
/30.7 13
/18 HRH2_HUMAN Histamine H2 receptor

8yut[1] A Guanine nucleotide-binding protein G(s) subunit al.. E 50.0
/29.9 24
/26 HRH2_HUMAN Histamine H2 receptor

7vl9[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 33.3
/27.1 15
/16 CCR1_HUMAN C-C chemokine receptor type 1

8xzh[3] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 35.0
/29.9 20
/23 APJ_HUMAN Apelin receptor

8xzf[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 40.0
/29.9 20
/23 APJ_HUMAN Apelin receptor

8xzf[1] F WN561[14 aa] A 24.0
/29.9 25
/27 APJ_HUMAN Apelin receptor

8xzh[1] F MM07[13 aa] A 28.6
/29.9 21
/25 APJ_HUMAN Apelin receptor

8xzj[1] F WN353[13 aa] A 23.8
/29.9 21
/24 APJ_HUMAN Apelin receptor

6oik[1] B GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. A 75.0
/29.8 4
/15 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Muscarinic ac..

7t8x[1] B GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. A 50.0
/29.8 8
/17 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,muscarinic ac..

7t90[3] B GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. A 75.0
/29.8 4
/13 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2

6lw5[1] B TRP-LYS-TYR-MET-VAL-QXV[6 aa] A 38.1
/30.4 21
/23 C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor ..

6omm[1] B Peptide agonist[6 aa] A 33.3
/29.8 15
/17 FPR2_HUMAN N-formyl peptide receptor 2

6omm[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 32.0
/29.8 25
/25 FPR2_HUMAN N-formyl peptide receptor 2

7t6s[2] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 35.0
/29.8 20
/20 FPR2_HUMAN N-formyl peptide receptor 2

7t6u[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. F 36.4
/29.8 22
/22 FPR2_HUMAN N-formyl peptide receptor 2

7t6u[1] E Synthetic peptide[8 aa] F 41.2
/29.8 17
/20 FPR2_HUMAN N-formyl peptide receptor 2

6do1[5] C Nanobody Nb.AT110i1[125 aa] A 18.2
/26.9 11
/21 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome ..

6os1[1] C TRV023 peptide[8 aa] A 50.0
/29.8 4
/23 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome ..

6os2[1] C TRV026 peptide[8 aa] A 57.1
/29.8 7
/27 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome ..

8xzg[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 35.3
/29.7 17
/17 APJ_HUMAN Apelin receptor

8xzg[1] D APEL_HUMAN Apelin-13[13 aa] E 30.4
/29.7 23
/27 APJ_HUMAN Apelin receptor

8u4r[8] A REGN7663 Fab light chain[111 aa] C 40.0
/29.6 5
/6 CXCR4_HUMAN C-X-C chemokine receptor type 4

8u4t[4] D REGN7663 Fab light chain[112 aa] C 0.0
/29.5 2
/3 CXCR4_HUMAN C-X-C chemokine receptor type 4

8u4r[8] B REGN7663 Fab heavy chain[125 aa] C 26.7
/29.6 15
/24 CXCR4_HUMAN C-X-C chemokine receptor type 4

8feg[1] F ACE-TYR-ALA-DTY-THR-THR-CYS-THR-DPN-XT9[10 aa] E 36.4
/29.4 11
/23 OPRK_HUMAN Kappa-type opioid receptor

8k2w[1] A Nb6[101 aa] B 36.4
/29.4 11
/11 C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t..

3oe0[2] B Polyphemusin analog, CXC chemokine receptor antago.. A 16.7
/29.3 24
/26 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

8dzs[1] B GNAZ_HUMAN Guanine nucleotide-binding protein G(z) subunit al.. A 62.5
/29.2 8
/19 OPRK_HUMAN Kappa-type opioid receptor

7xjj[1] C GALA_HUMAN Galanin[17 aa] D 27.3
/29.2 11
/18 GALR1_HUMAN Galanin receptor type 1

8ic0[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 36.4
/29.2 11
/21 CXCR1_HUMAN C-X-C chemokine receptor type 1

8ic0[1] F IL8_HUMAN Interleukin-8[69 aa] A 26.7
/29.2 15
/25 CXCR1_HUMAN C-X-C chemokine receptor type 1

7l1u[1] F OREX_HUMAN Orexin[10 aa] E 25.0
/29.2 20
/21 Q548Y0_HUMAN Hypocretin receptor type 2

7l1v[1] F Synthetic nanobody 51 (Sb51)[111 aa] E 22.2
/29.1 18
/20 Q548Y0_HUMAN Hypocretin receptor type 2

8dzq[1] D GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. E 50.0
/29.1 8
/21 OPRK_HUMAN Kappa-type opioid receptor

6meo[2] A Q70145_9HIV1 Envelope glycoprotein gp160[398 aa] C 9.5
/29.0 21
/35 CCR5_HUMAN C-C chemokine receptor type 5

5uiw[1] B CCL5_HUMAN C-C motif chemokine 5[68 aa] A 12.9
/26.7 31
/40 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin chimera

7o7f[1] E CCL5_HUMAN C-C motif chemokine 5[67 aa] C 12.5
/29.0 24
/31 CCR5_HUMAN C-C chemokine receptor type 5

7o7f[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. C 30.8
/29.0 13
/17 CCR5_HUMAN C-C chemokine receptor type 5

7ymj[1] B Nb6[116 aa] A 44.4
/26.9 9
/9 alpha1A-adrenergic receptor

8hn1[1] C Nb6[111 aa] B 50.0
/27.3 12
/12 ADA1A_HUMAN Alpha-1A adrenergic receptor

8hnn[1] A Nb6[114 aa] B 33.3
/28.9 12
/12 C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t..

8hnk[4] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. D 21.4
/28.4 14
/22 C562_ECOLX CXCR3_HUMAN LUCI_OPLGR Soluble cytochrome b562,C-X-C chemokine receptor t..

8k2x[1] F CXL10_HUMAN C-X-C motif chemokine 10[8 aa] D 14.3
/28.9 14
/17 C562_ECOLX CXCR3_HUMAN LUCI_OPLGR Soluble cytochrome b562,C-X-C chemokine receptor t..

6dde[2] F DAMGO[5 aa] E 20.0
/28.8 15
/15 OPRM_MOUSE Mu-type opioid receptor

8k9k[2] B DAMGO[5 aa] A 26.7
/28.8 15
/15 C562_ECOLX OPRM_HUMAN Soluble cytochrome b562,Mu-type opioid receptor

7ezh[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. C 50.0
/33.7 14
/19 CCKAR_HUMAN Cholecystokinin receptor type A

8efq[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 38.9
/28.8 18
/21 OPRM_HUMAN Mu-type opioid receptor

8efq[1] D DAMGO[4 aa] E 30.8
/28.8 13
/13 OPRM_HUMAN Mu-type opioid receptor

8k9k[2] C F6VL43_MACMU G protein subunit alpha i3[224 aa] A 36.8
/28.8 19
/22 C562_ECOLX OPRM_HUMAN Soluble cytochrome b562,Mu-type opioid receptor

8jbf[1] F Guanine nucleotide-binding protein Gq subunit alph.. A 42.1
/26.0 19
/19 NK3R_HUMAN Neuromedin-K receptor

8jbg[1] F Guanine nucleotide-binding protein Gq (G324)[229 a.. A 41.2
/28.6 17
/20 Neuromedin-K receptor (NK3R-pFastbac1)

8jbg[1] E TKNK_HUMAN Neurokinin-B[8 aa] A 16.7
/28.6 12
/23 Neuromedin-K receptor (NK3R-pFastbac1)

7t2g[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. D 25.9
/28.5 27
/27 C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor

8hnk[1] E CXL11_HUMAN C-X-C motif chemokine 11[73 aa] D 16.7
/28.4 24
/31 C562_ECOLX CXCR3_HUMAN LUCI_OPLGR Soluble cytochrome b562,C-X-C chemokine receptor t..

8jbh[1] E TKN1_HUMAN peptide from Protachykinin-1[7 aa] A 6.7
/28.4 15
/23 NK3R-pFastbac1

8jbh[1] F Guanine nucleotide-binding protein Gq subunit alph.. A 50.0
/28.4 16
/19 NK3R-pFastbac1

7ul4[1] B Megabody 6[65 aa] A 40.0
/28.4 10
/10 OPRM_MOUSE Mu-type opioid receptor

8ef5[4] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 29.2
/28.4 24
/24 OPRM_HUMAN Mu-type opioid receptor

8f7q[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 30.4
/28.4 23
/23 OPRM_HUMAN Mu-type opioid receptor

8f7q[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. G 0.0
/28.4 1
/1 OPRM_HUMAN Mu-type opioid receptor

8efl[1] G GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. F 31.2
/28.4 16
/16 OPRM_HUMAN Mu-type opioid receptor

8efo[1] G GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. F 35.0
/28.4 20
/20 OPRM_HUMAN Mu-type opioid receptor

8f7q[2] B COLI_HUMAN Beta-endorphin[21 aa] A 29.4
/28.4 17
/17 OPRM_HUMAN Mu-type opioid receptor

8f7r[2] B endomorphin[5 aa] A 23.5
/28.4 17
/17 OPRM_HUMAN Mu-type opioid receptor

8f7r[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 28.6
/28.4 21
/21 OPRM_HUMAN Mu-type opioid receptor

8f7r[1] I GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. G 33.3
/28.4 18
/18 OPRM_HUMAN Mu-type opioid receptor

6dde[6] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 38.1
/28.8 21
/22 OPRM_MOUSE Mu-type opioid receptor

7sbf[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 38.9
/29.0 18
/21 C562_ECOLX OPRM_MOUSE Soluble cytochrome b562, Mu-type opioid receptor c..

7y1f[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. C 60.0
/28.4 10
/24 OPRK_HUMAN Kappa-type opioid receptor

7y1f[1] B Dynorphin[9 aa] C 30.8
/28.4 13
/24 OPRK_HUMAN Kappa-type opioid receptor

8efb[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 25.0
/28.4 24
/24 OPRM_HUMAN Mu-type opioid receptor

8f7w[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 44.4
/28.4 9
/20 OPRK_HUMAN Kappa-type opioid receptor

8f7w[1] B PDYN_HUMAN Dynorphin[8 aa] A 36.4
/28.4 11
/20 OPRK_HUMAN Kappa-type opioid receptor

8u4n[4] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. D 22.2
/28.0 18
/20 CXCR4_HUMAN C-X-C chemokine receptor type 4

8u4o[1] E SDF1_HUMAN Stromal cell-derived factor 1[65 aa] A 30.8
/28.4 13
/19 CXCR4_HUMAN C-X-C chemokine receptor type 4

8u4q[1] A REGN7663 Fab light chain[219 aa] C 50.0
/28.4 4
/4 CXCR4_HUMAN C-X-C chemokine receptor type 4

8u4q[1] B REGN7663 Fab heavy chain[219 aa] C 16.7
/28.4 12
/21 CXCR4_HUMAN C-X-C chemokine receptor type 4

8ef5[1] G GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. F 31.6
/28.3 19
/19 OPRM_HUMAN Mu-type opioid receptor

8qot[1] B Nanobody E (NbE)[125 aa] A 15.0
/28.3 20
/20 OPRM_MOUSE Mu-type opioid receptor

7vla[2] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 28.6
/27.1 14
/14 CCR1_HUMAN C-C chemokine receptor type 1

7wic[2] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. B 52.9
/27.2 17
/19 SSR2_HUMAN Somatostatin receptor type 2

5c1m[2] B Nanobody 39[118 aa] A 33.3
/28.1 21
/23 OPRM_MOUSE Mu-type opioid receptor

6b73[2] D Nanobody[122 aa] A 46.2
/28.9 13
/21 C562_ECOLX OPRK_HUMAN Soluble cytochrome b562, kappa-type opioid recepto..

7yit[1] B Nanobody39[109 aa] A 55.6
/28.9 9
/16 OPRK_HUMAN Kappa-type opioid receptor

5vbl[1] A agonist peptide[17 aa] B 15.0
/27.9 20
/26 APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor,Rubredoxin,Apelin receptor Chimera..

6knm[1] B Single domain antibody JN241[129 aa] A 12.0
/27.9 25
/32 APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor,Rubredoxin,Apelin receptor

7w55[1] A Guanine nucleotide-binding protein G(q) subunit al.. F 25.0
/26.7 24
/29 Neuromedin-U receptor 2

7wkd[1] A Gq[232 aa] E 33.3
/33.7 9
/19 TRFR_HUMAN Thyrotropin-releasing hormone receptor

8wz2[1] A G-alpha q[232 aa] F 27.3
/27.8 22
/23 QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor

8wz2[1] E OX26_MOUSE Orexigenic neuropeptide QRFP[26 aa] F 24.1
/27.8 29
/30 QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor

7xa3[1] B CCL2_HUMAN C-C motif chemokine 2[69 aa] A 22.2
/27.8 18
/26 CCR2_HUMAN Isoform B of C-C chemokine receptor type 2

7xa3[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 38.5
/27.8 13
/17 CCR2_HUMAN Isoform B of C-C chemokine receptor type 2

7xat[3] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 36.8
/27.2 19
/22 SSR2_HUMAN Somatostatin receptor type 2,LargeBit

7xau[1] F Octreotide[7 aa] A 36.8
/27.8 19
/19 SSR2_HUMAN Somatostatin receptor type 2,LargeBit

7xav[1] F Lanreotide[6 aa] A 33.3
/27.8 15
/15 SSR2_HUMAN Somatostatin receptor type 2,LargeBit

8zh8[1] G OX26_HUMAN QRF-amide[25 aa] A 25.8
/27.8 31
/44 QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor

6tko[1] B ARRB1_HUMAN Beta-arrestin-1[344 aa] A 36.0
/30.3 25
/42 ADRB1_MELGA Beta-1 adrenergic receptor

7r0c[1] C ARRB1_HUMAN Arrestin2[353 aa] A 33.3
/53.8 15
/24 V2R_HUMAN Vasopressin V2 receptor

7srs[1] D ARRB1_HUMAN Isoform 1B of Beta-arrestin-1[355 aa] C 33.3
/27.7 15
/22 5-hydroxytryptamine receptor 2B

7srs[1] A Anti-5HT2BR Fab light chain[107 aa] C 0.0
/27.7 4
/4 5-hydroxytryptamine receptor 2B

7srs[1] B Anti-5HT2BR Fab heavy chain[127 aa] C 12.5
/27.7 8
/9 5-hydroxytryptamine receptor 2B

8wst[1] D MCH_HUMAN Pro-MCH[15 aa] F 16.7
/27.7 24
/27 MCHR2_HUMAN Melanin-concentrating hormone receptor 2

7t10[2] B GNAI3_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 36.4
/28.5 11
/13 SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2,Kappa-type opioid rec..

7ul5[1] B Nanobody 6[86 aa] A 36.4
/27.5 11
/11 SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2

5tud[2] B Anti-5-HT2B Fab light chain[211 aa] A 0.0
/27.5 5
/5 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B,Soluble cytochrome..

5tud[2] C Anti-5-HT2B Fab heavy chain[229 aa] A 14.3
/27.5 14
/18 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B,Soluble cytochrome..

7y27[1] F somatostatin-14[12 aa] D 30.8
/27.5 13
/13 SSR2_HUMAN Somatostatin receptor type 2

7w57[1] A Guanine nucleotide-binding protein G(q) subunit al.. F 25.0
/27.4 20
/25 Neuromedin-U receptor 2

7w57[1] C NMS_HUMAN Neuromedin-S[12 aa] F 11.5
/27.4 26
/29 Neuromedin-U receptor 2

8hn1[1] A 3SI1A_DENAN Toxin AdTx1[65 aa] B 4.5
/27.3 22
/22 ADA1A_HUMAN Alpha-1A adrenergic receptor

7t10[1] E SMS_HUMAN Somatostatin-14[14 aa] A 38.1
/28.5 21
/21 SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2,Kappa-type opioid rec..

7wic[1] A somatostatin-14[14 aa] B 34.8
/27.2 23
/23 SSR2_HUMAN Somatostatin receptor type 2

7xmr[1] E SMS_HUMAN Somatostatin-14[14 aa] A 30.8
/27.2 26
/26 SSR2_HUMAN Somatostatin receptor type 2

7t11[1] E Octreotide[8 aa] F 23.8
/27.6 21
/21 SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2,Kappa-type opioid rec..

7yae[1] F DPN-CYS-PHE-DTR-LYS-THR-CYS-THO[8 aa] E 25.0
/27.2 16
/16 SSR2_HUMAN Somatostatin receptor type 2

7xmr[1] B GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 35.3
/27.2 17
/19 SSR2_HUMAN Somatostatin receptor type 2

7yac[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. D 37.5
/27.2 16
/19 SSR2_HUMAN Somatostatin receptor type 2

7yae[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 43.8
/27.2 16
/19 SSR2_HUMAN Somatostatin receptor type 2

7vl9[2] D CCL15_HUMAN CCL15(26-92)[65 aa] E 12.5
/27.1 24
/35 CCR1_HUMAN C-C chemokine receptor type 1

7xk8[1] A NMU_HUMAN Neuromedin-U-25[26 aa] B 14.3
/27.1 21
/24 NMUR2_HUMAN Neuromedin-U receptor 2

7xk8[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. B 38.5
/27.1 13
/16 NMUR2_HUMAN Neuromedin-U receptor 2

6do1[1] E Nanobody Nb.AT110i1[58 aa] A 0.0
/26.9 3
/3 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome ..

6jod[1] B Angiotensin II[8 aa] A 36.8
/34.3 19
/24 AGTR2_HUMAN Type-2 angiotensin II receptor

6os0[1] C ANGT_HUMAN Angiotensinogen[8 aa] A 28.6
/26.9 7
/26 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome ..

4rws[1] B VMI2_HHV8P Viral macrophage inflammatory protein 2[70 aa] A 23.5
/26.9 17
/26 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4/Endolysin chimeric..

7yon[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. E 30.8
/26.8 13
/14 NPY2R_HUMAN Neuropeptide Y receptor type 2

7yon[1] D PYY_HUMAN Peptide YY(3-36)[25 aa] E 33.3
/26.8 21
/23 NPY2R_HUMAN Neuropeptide Y receptor type 2

7yoo[1] D NPY_HUMAN Neuropeptide Y[29 aa] E 29.2
/26.8 24
/28 NPY2R_HUMAN Neuropeptide Y receptor type 2

7w55[1] C NMU_HUMAN Neuromedin-U-25[9 aa] F 12.0
/26.7 25
/27 Neuromedin-U receptor 2

8gei[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 11.1
/26.4 9
/9 ADRB2_HUMAN Beta-2 adrenergic receptor

8ge8[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 31.2
/26.2 16
/17 ADRB2_HUMAN Beta-2 adrenergic receptor

8gea[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 33.3
/26.2 15
/16 ADRB2_HUMAN Beta-2 adrenergic receptor

7x9a[1] E NPY_HUMAN Neuropeptide Y[36 aa] A 14.3
/24.5 35
/42 NPY1R_HUMAN Neuropeptide Y receptor type 1

7x9b[1] E NPY_HUMAN Neuropeptide Y[36 aa] D 31.8
/26.1 22
/22 NPY2R_HUMAN Neuropeptide Y receptor type 2

7x9b[1] A GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. D 38.9
/26.1 18
/20 NPY2R_HUMAN Neuropeptide Y receptor type 2

3sn6[1] A GNAS2_BOVIN Guanine nucleotide-binding protein G(s) subunit al.. D 34.8
/26.1 23
/25 ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor

8jbf[1] E Senktide[8 aa] A 9.1
/26.0 22
/24 NK3R_HUMAN Neuromedin-K receptor

7vgx[1] B NPY_HUMAN Neuropeptide Y[22 aa] A 16.7
/25.9 24
/26 NPY1R_HUMAN Neuropeptide Y receptor type 1

7vgx[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 33.3
/25.9 12
/14 NPY1R_HUMAN Neuropeptide Y receptor type 1

8gg5[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 27.8
/25.8 18
/19 ADRB2_HUMAN Beta-2 adrenergic receptor

8gg6[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 35.7
/25.8 14
/14 ADRB2_HUMAN Beta-2 adrenergic receptor

8gg8[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 31.2
/25.5 16
/16 ADRB2_HUMAN Beta-2 adrenergic receptor

5jqh[2] D Nanobody60, Nb60[120 aa] A 25.0
/25.1 20
/25 ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor

8unq[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 30.8
/25.4 13
/13 ADRB2_HUMAN Beta-2 adrenergic receptor

8uns[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 33.3
/25.4 12
/12 ADRB2_HUMAN Beta-2 adrenergic receptor

8unx[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 28.6
/25.4 14
/15 ADRB2_HUMAN Beta-2 adrenergic receptor

8uny[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. D 38.5
/25.4 13
/13 ADRB2_HUMAN Beta-2 adrenergic receptor

6mxt[1] B nanobody Nb71[122 aa] A 26.3
/25.3 19
/25 D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera

4gbr[1] B LYS_BPT4 Lysozyme[162 aa] A 20.0
/25.2 5
/7 ADRB2_HUMAN Beta-2 adrenergic receptor

7xna[1] B CYN 154806[10 aa] A 0.0
/25.1 10
/23 SSR2_HUMAN XYNA_BACCI SSR2_HUMAN Somatostatin receptor type 2,Endo-1,4-beta-xylanas..

4lde[5] B Camelid Antibody Fragment[120 aa] A 35.3
/25.1 17
/20 LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor

6h7l[8] C Camelid antibody fragment Nb6B9[120 aa] B 33.3
/32.0 24
/27 ADRB1_MELGA Beta-1 adrenergic receptor

7bz2[1] A GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. E 31.2
/24.7 16
/18 Beta2 adrenergic receptor

6osa[1] B JMV449[6 aa] A 7.7
/24.4 13
/18 NTR1_HUMAN Neurotensin receptor type 1

6osa[1] C GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. A 31.6
/24.4 19
/21 NTR1_HUMAN Neurotensin receptor type 1

2ksa[1] B TKN1_HUMAN Substance P[11 aa] A 0.0
/23.6 2
/7 NK1R_HUMAN Substance-P receptor

2ksb[1] B TKN1_HUMAN Substance P[11 aa] A 20.0
/23.6 5
/12 NK1R_HUMAN Substance-P receptor

8u26[1] F TKN1_HUMAN Protachykinin-1[11 aa] E 30.0
/23.6 10
/21 NK1R_HUMAN Substance-P receptor

7p00[1] F Substance P[12 aa] E 18.8
/23.6 16
/28 NK1R_HUMAN Substance-P receptor

7rmg[2] C TKN1_HUMAN Substance P[12 aa] B 21.4
/23.4 14
/23 NK1R_HUMAN Substance-P receptor

7p02[1] F TKN1_HUMAN Protachykinin-1[10 aa] E 13.3
/23.6 15
/26 NK1R_HUMAN Substance-P receptor

7rmg[2] A GNAS2_HUMAN GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. B 36.4
/23.4 11
/17 NK1R_HUMAN Substance-P receptor

7rmi[1] C Substance P 6-11[7 aa] B 14.3
/23.6 14
/22 NK1R_HUMAN Substance-P receptor

3dqb[1] B GNAT1_BOVIN 11meric peptide form Guanine nucleotide-binding pr.. A 40.0
/21.0 15
/15 OPSD_BOVIN Rhodopsin

3pqr[9] B GNAT1_BOVIN Guanine nucleotide-binding protein G(t) subunit al.. A 42.9
/21.0 14
/14 OPSD_BOVIN Rhodopsin

4pxf[2] B ARRS_BOVIN S-arrestin[7 aa] A 28.6
/21.0 7
/7 OPSD_BOVIN Rhodopsin

4x1h[1] B C-terminal derived peptide of guanine nucleotide-b.. A 46.2
/21.0 13
/13 OPSD_BOVIN Rhodopsin

6oy9[1] A GNAT1_BOVIN Gt-alpha/Gi1-alpha chimera[223 aa] D 36.8
/21.0 19
/19 OPSD_BOVIN Rhodopsin

6oya[1] A GNAT1_BOVIN Gt-alpha/Gi1-alpha chimera[205 aa] E 27.8
/21.0 18
/18 OPSD_BOVIN Rhodopsin

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

COMPOUND

424 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

6tpk[1] B NU2
(3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydr.. A 76.9
/62.9 13
/13 OXYR_HUMAN Oxytocin receptor

2y03[2] G 5FW
ISOPRENALINE[15 atoms] A 33.3
/32.0 12
/12 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

6h7j[2] G 5FW
ISOPRENALINE[15 atoms] B 28.6
/32.0 14
/14 ADRB1_MELGA Beta-1 adrenergic receptor

7jjo[3] F 5FW
ISOPRENALINE[15 atoms] E 27.3
/31.5 11
/11 Beta1-Adrenergic Receptor

7xjh[1] F 5FW
ISOPRENALINE[15 atoms] E 0.0
/36.6 4
/12 ADRB3_CANLF Beta-3 adrenergic receptor

7dh5[1] F H6U
2-(2-azanyl-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-oxi.. E 0.0
/36.6 4
/17 ADRB3_CANLF Beta-3 adrenergic receptor

7xji[1] F EI5
3-[3-[2-[[(2~{S})-2-(3-chlorophenyl)-2-oxidanyl-et.. D 33.3
/36.6 3
/14 ADRB3_CANLF Beta-3 adrenergic receptor

7f9y[1] G OCA
OCTANOIC ACID (CAPRYLIC ACID)[9 atoms] F 16.7
/35.3 6
/7 Soluble cytochrome b562

5unf[3] C 8ES
N-benzyl-N-(2-ethyl-4-oxo-3-{[2'-(2H-tetrazol-5-yl.. A 38.5
/34.7 13
/20 C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor ..

7jni[2] C VFD
Olodanrigan[38 atoms] A 38.5
/34.3 13
/17 C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece..

7jni[1] K HEZ
HEXANE-1,6-DIOL[8 atoms] A 100.0
/34.3 2
/5 C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece..

5unh[2] C 8EM
N-[(furan-2-yl)methyl]-N-(4-oxo-2-propyl-3-{[2'-(2.. A 37.5
/33.3 16
/23 C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece..

7na8[1] F 1KD
1-(methanesulfonyl)-1'-(2-methyl-L-alanyl-O-benzyl.. E 33.3
/34.0 12
/19 GHSR_HUMAN Growth hormone secretagogue receptor type 1

4ea3[4] C 0NN
1-benzyl-N-[3-(1'H,3H-spiro[2-benzofuran-1,4'-pipe.. A 43.8
/30.9 16
/16 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

5dhg[4] C DGV
1-benzyl-N-{3-[4-(2,6-dichlorophenyl)piperidin-1-y.. A 46.2
/29.8 13
/14 C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor

6ko5[1] D 8QX
6-(4-bromanyl-2-fluoranyl-phenoxy)-2-methyl-3-[[(3.. A 11.1
/33.8 9
/16 C562_ECOLX GHSR_HUMAN Chimera of Soluble cytochrome b562 and Growth horm..

7xov[1] F IA1
2-[2-[[4-(4-chloranyl-2,5-dimethoxy-phenyl)-5-(2-c.. E 5.6
/33.7 18
/23 CCKAR_HUMAN Cholecystokinin receptor type A

8th4[1] E LSN
[2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol.. A 14.3
/33.6 7
/15 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor Soluble cytochrome ..

7f8u[1] B 1OE
2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamo.. A 8.3
/33.0 12
/13 CCKAR_HUMAN ENLYS_BPT4 CCKAR_HUMAN Fusion protein of Cholecystokinin receptor type A ..

7f8y[1] B 1OZ
N-[(3S)-1-methyl-2-oxidanylidene-5-phenyl-3H-1,4-b.. A 8.3
/33.0 12
/14 CCKAR_HUMAN ENLYS_BPT4 CCKAR_HUMAN fusion protein of Cholecystokinin receptor type A ..

8xio[1] F A1D5D
(2~{S})-~{N}-[(4~{S})-6-azanyl-2,2,4-trimethyl-hex.. A 40.0
/32.6 15
/16 SSR1_HUMAN Somatostatin receptor type 1

4ej4[1] B EJ4
(4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14.. A 20.0
/32.5 5
/12 OPRD_MOUSE LYS_BPT4 OPRD_MOUSE Delta-type opioid receptor, Lysozyme chimera

4n6h[1] T EJ4
(4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14.. A 41.7
/32.4 12
/13 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4zjc[1] B 4OT
[5-(2-fluorophenyl)-2-methyl-1,3-thiazol-4-yl]{(2S.. A 8.3
/32.0 12
/16 OX1R_HUMAN Q9V2J8_PYRAB OX1R_HUMAN human OX1R fusion protein to P.abysii glycogen syn..

4ami[2] C G90
2-[(2S)-3-[[1-(1H-indol-3-yl)-2-methyl-propan-2-yl.. A 37.5
/32.0 16
/18 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

2vt4[4] J D10
DECANE[10 atoms] A 0.0
/31.7 2
/2 ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR

2y04[2] J 68H
SALBUTAMOL[17 atoms] A 36.4
/32.3 11
/11 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

6h7m[2] J 68H
SALBUTAMOL[17 atoms] B 35.7
/32.0 14
/14 ADRB1_MELGA Beta-1 adrenergic receptor

6h7n[2] G FVK
~{N}-[2-[[(2~{S})-2-oxidanyl-3-(4-oxidanylphenoxy).. B 29.4
/32.0 17
/17 ADRB1_MELGA Beta-1 adrenergic receptor

6me9[2] C JEV
N-{2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]fura.. A 8.3
/28.8 12
/16 C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B..

7vh0[1] F JEV
N-{2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]fura.. A 8.3
/31.6 12
/12 MTR1B_HUMAN Melatonin receptor type 1B

5dhh[3] H DGW
(5S,7S)-7-{[4-(2,6-dichlorophenyl)piperidin-1-yl]m.. A 33.3
/30.8 15
/16 C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor

2y02[2] J WHJ
CARMOTEROL[27 atoms] A 31.2
/32.3 16
/17 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

3zpq[2] I XF5
4-(PIPERAZIN-1-YL)-1H-INDOLE[15 atoms] A 55.6
/32.3 9
/9 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

3zpr[2] G 3WC
4-METHYL-2-(PIPERAZIN-1-YL) QUINOLINE[17 atoms] A 40.0
/31.8 15
/15 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4amj[2] C CVD
(2S)-1-(8H-CARBAZOL-4-YLOXY)-3-[2-(2-METHOXYPHENOX.. A 40.0
/32.3 15
/15 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

2vt4[11] E P32
4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-.. A 35.3
/31.7 17
/17 ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR

6h7o[2] G P32
4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-.. B 35.3
/32.0 17
/17 ADRB1_MELGA Beta-1 adrenergic receptor

8dcs[1] F P32
4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-.. E 23.5
/31.5 17
/17 ENLYS_BPT4 Endolysin,Endolysin,Beta-1 adrenergic receptor chi..

2y00[4] J Y00
DOBUTAMINE[22 atoms] A 35.3
/32.3 17
/17 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

6h7l[2] M Y00
DOBUTAMINE[22 atoms] B 27.8
/32.0 18
/18 ADRB1_MELGA Beta-1 adrenergic receptor

8dcr[1] F Y00
DOBUTAMINE[22 atoms] E 22.2
/31.5 18
/18 ENLYS_BPT4 Endolysin,Endolysin,Beta-1 adrenergic receptor chi..

6pt3[2] C OWY
4-[(R)-[(2S,5R)-4-benzyl-2,5-dimethylpiperazin-1-y.. A 47.1
/31.5 17
/18 Delta opioid receptor

7f83[2] E 1KQ
2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-[2-[.. A 30.0
/32.6 10
/19 GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl..

7xmt[1] F I8B
(2~{S})-2-[[(2~{S})-4-azanyl-2-[(4-methylnaphthale.. A 40.0
/31.2 15
/15 SSR4_HUMAN Somatostatin receptor type 4

6rz9[1] B KO5
(2~{S})-8-[[4-[4-(5-fluoranyl-2-methyl-phenyl)buto.. A 7.1
/31.1 14
/19 CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom..

2ycz[2] C I32
4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-.. A 40.0
/31.0 15
/15 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4bvn[2] E MHA
(CARBAMOYLMETHYL-CARBOXYMETHYL-AMINO)-ACETIC ACID[.. A 0.0
/30.4 2
/3 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

5a8e[1] D XTK
4-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-7-me.. A 35.3
/30.8 17
/17 ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR

8pok[1] F HSM
HISTAMINE[8 atoms] A 20.0
/30.7 5
/5 HRH2_HUMAN Histamine H2 receptor

6me3[2] B JEY
N-[2-(5-methoxy-2-phenyl-1H-indol-3-yl)ethyl]aceta.. A 0.0
/30.6 6
/16 MTR1A_HUMAN Q9V2J8_PYRAB MTR1A_HUMAN chimera protein of Melatonin receptor type 1A and ..

6me6[6] C JEY
N-[2-(5-methoxy-2-phenyl-1H-indol-3-yl)ethyl]aceta.. A 6.7
/28.8 15
/19 C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B..

6me4[1] B ML2
N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetami.. A 0.0
/30.6 6
/14 MTR1A_HUMAN Q9V2J8_PYRAB MTR1A_HUMAN chimera protein of Melatonin receptor type 1A and ..

6me5[1] B AWY
~{N}-[2-(7-methoxynaphthalen-1-yl)ethyl]ethanamide.. A 0.0
/30.6 4
/12 MTR1A_HUMAN Q9V2J8_PYRAB MTR1A_HUMAN chimera protein of Melatonin receptor type 1A and ..

6wha[1] F U0G
4-(2-{[(2-hydroxyphenyl)methyl]amino}ethyl)-2,5-di.. A 37.5
/30.3 8
/9 C562_ECOLX 5HT2A_HUMAN Soluble cytochrome b562,5-hydroxytryptamine recept..

7sus[1] C 8EH
(1R,2S)-N-[4-(2,6-dimethoxyphenyl)-5-(6-methylpyri.. A 13.3
/28.2 15
/16 APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor, with Rubredoxin insertion

7w0l[3] G 8EH
(1R,2S)-N-[4-(2,6-dimethoxyphenyl)-5-(6-methylpyri.. D 33.3
/30.1 12
/13 C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor

4ib4[23] D CLR
CHOLESTEROL[28 atoms] A 40.0
/27.9 5
/8 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

5c1m[160] E CLR
CHOLESTEROL[28 atoms] A 14.3
/28.1 7
/7 OPRM_MOUSE Mu-type opioid receptor

5jqh[2] F CLR
CHOLESTEROL[28 atoms] A 25.0
/25.1 4
/4 ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor

6lw5[1] C CLR
CHOLESTEROL[28 atoms] A 33.3
/30.4 3
/3 C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor ..

6omm[1] H CLR
CHOLESTEROL[28 atoms] A 33.3
/29.8 6
/6 FPR2_HUMAN N-formyl peptide receptor 2

6omm[1] I CLR
CHOLESTEROL[28 atoms] A 33.3
/29.8 3
/3 FPR2_HUMAN N-formyl peptide receptor 2

6pt2[1] E CLR
CHOLESTEROL[28 atoms] A 33.3
/31.5 6
/6 Delta opioid receptor

6tpk[1] C CLR
CHOLESTEROL[28 atoms] A 83.3
/62.9 6
/6 OXYR_HUMAN Oxytocin receptor

6v9s[1] C CLR
CHOLESTEROL[28 atoms] A 50.0
/28.3 2
/5 OX1R_HUMAN Q9V2J8_PYRAB OX1R_HUMAN Orexin receptor type 1,GlgA glycogen synthase chim..

6vi4[5] G CLR
CHOLESTEROL[28 atoms] B 42.9
/28.5 7
/7 OPRK_HUMAN Kappa opioid receptor

6wgt[1] E CLR
CHOLESTEROL[28 atoms] A 11.1
/26.1 9
/9 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wgt[1] I CLR
CHOLESTEROL[28 atoms] A 42.9
/26.1 7
/7 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7dw9[1] I CLR
CHOLESTEROL[28 atoms] A 71.4
/52.3 7
/7 V2R_HUMAN Vasopressin V2 receptor

7dw9[1] J CLR
CHOLESTEROL[28 atoms] A 50.0
/52.3 4
/4 V2R_HUMAN Vasopressin V2 receptor

7f9y[1] I CLR
CHOLESTEROL[28 atoms] F 77.8
/35.3 9
/9 Soluble cytochrome b562

7na7[2] H CLR
CHOLESTEROL[28 atoms] E 20.0
/34.6 10
/10 GHSR_HUMAN Growth hormone secretagogue receptor type 1

7p00[2] G CLR
CHOLESTEROL[28 atoms] E 37.5
/23.6 8
/9 NK1R_HUMAN Substance-P receptor

7t2g[1] F CLR
CHOLESTEROL[28 atoms] D 33.3
/28.5 9
/9 C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor

7t2g[1] G CLR
CHOLESTEROL[28 atoms] D 20.0
/28.5 10
/10 C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor

7vl9[2] G CLR
CHOLESTEROL[28 atoms] E 10.0
/27.1 10
/10 CCR1_HUMAN C-C chemokine receptor type 1

7wc8[1] L CLR
CHOLESTEROL[21 atoms] A 66.7
/28.0 3
/3 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

7wq3[1] G CLR
CHOLESTEROL[28 atoms] A 0.0
/28.2 3
/4 GALR1_HUMAN Galanin receptor type 1

7wq3[1] K CLR
CHOLESTEROL[28 atoms] A 12.5
/28.2 8
/8 GALR1_HUMAN Galanin receptor type 1

7wq4[1] H CLR
CHOLESTEROL[28 atoms] A 0.0
/33.2 4
/4 GALR2_HUMAN Galanin receptor type 2

7y27[1] G CLR
CHOLESTEROL[28 atoms] D 100.0
/27.5 1
/1 SSR2_HUMAN Somatostatin receptor type 2

7yae[1] H CLR
CHOLESTEROL[28 atoms] E 0.0
/27.2 3
/3 SSR2_HUMAN Somatostatin receptor type 2

8f7q[4] J CLR
CHOLESTEROL[28 atoms] A 25.0
/28.4 8
/8 OPRM_HUMAN Mu-type opioid receptor

8f7w[1] G CLR
CHOLESTEROL[28 atoms] A 14.3
/28.4 7
/7 OPRK_HUMAN Kappa-type opioid receptor

8f7w[1] I CLR
CHOLESTEROL[28 atoms] A 0.0
/28.4 1
/3 OPRK_HUMAN Kappa-type opioid receptor

8u4t[4] Q CLR
CHOLESTEROL[28 atoms] C 80.0
/29.5 5
/5 CXCR4_HUMAN C-X-C chemokine receptor type 4

8yut[1] F A1D67
5-(2-azanylethyl)-4-methyl-1,3-thiazol-2-amine[10 .. E 11.1
/29.9 9
/9 HRH2_HUMAN Histamine H2 receptor

4mqs[2] C IXO
4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethyl.. A 12.5
/29.8 8
/14 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2

6oik[1] F IXO
4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethyl.. A 14.3
/29.8 7
/13 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Muscarinic ac..

4mqt[1] D 2CU
3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-me.. A 18.2
/31.0 11
/11 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2

6oik[3] G 2CU
3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-me.. A 0.0
/29.8 5
/8 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Muscarinic ac..

7t8x[4] F ACH
ACETYLCHOLINE[10 atoms] A 0.0
/29.8 4
/9 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,muscarinic ac..

7t6s[1] F FUI
N-(4-chlorophenyl)-N'-[1-methyl-3-oxo-2-phenyl-5-(.. E 30.0
/29.8 10
/13 FPR2_HUMAN N-formyl peptide receptor 2

2y00[10] C Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] A 0.0
/32.3 8
/8 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

2y00[12] D Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] A 44.4
/32.3 9
/9 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

2y00[14] L Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] A 40.0
/32.3 5
/5 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

7mbx[2] G Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] F 50.0
/33.7 6
/7 CCKAR_HUMAN Cholecystokinin receptor type A

8th3[1] E Y01
CHOLESTEROL HEMISUCCINATE[35 atoms] A 37.5
/29.8 8
/8 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN AT118-H nanobody, Type-1 angiotensin II receptor, ..

8xzi[1] F A1D5N
(3~{S})-5-methyl-3-[[1-pentan-3-yl-2-(thiophen-2-y.. A 26.7
/29.6 15
/16 APJ_HUMAN Apelin receptor

6to7[14] BA PGW
(1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydro.. A 10.0
/29.0 10
/10 OX1R_HUMAN Orexin receptor type 1

6tos[4] Z PGW
(1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydro.. B 31.2
/28.9 16
/17 OX1R_HUMAN Orexin receptor type 1

8v6u[1] F YEQ
4-{(3R)-1-[(1R)-1-(pyrimidin-2-yl)ethyl]piperidin-.. A 20.0
/29.6 5
/8 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A

6tp4[1] C NRZ
(2~{S})-~{N}-(3,5-dimethylphenyl)-1-(4-methoxyphen.. A 15.4
/29.5 13
/13 OX1R_HUMAN Orexin receptor type 1

8u4s[7] K D21
(2R)-1-(hexadecanoyloxy)-3-(phosphonooxy)propan-2-.. C 20.0
/28.4 5
/5 CXCR4_HUMAN C-X-C chemokine receptor type 4

8u4s[7] N D21
(2R)-1-(hexadecanoyloxy)-3-(phosphonooxy)propan-2-.. C 25.0
/28.4 4
/4 CXCR4_HUMAN C-X-C chemokine receptor type 4

7br3[1] L F5O
4-[[(1R)-2-[5-(2-fluoranyl-3-methoxy-phenyl)-3-[[2.. A 28.6
/29.5 14
/19 GNRHR_HUMAN Q9V2J8_PYRAB GNRHR_HUMAN Gonadotropin-releasing hormone receptor,GlgA glyco..

8k2w[1] E LPC
[1-MYRISTOYL-GLYCEROL-3-YL]PHOSPHONYLCHOLINE[31 at.. B 12.5
/29.4 8
/8 C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t..

8k2w[1] F FI6
N-[(1R)-1-[3-(4-ethoxyphenyl)-4-oxidanylidene-pyri.. B 25.0
/29.4 8
/9 C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t..

4s0v[1] B SUV
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,.. A 10.5
/27.3 19
/19 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Human Orexin receptor type 2 fusion protein to P. ..

4zj8[1] B SUV
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,.. A 7.1
/32.0 14
/19 OX1R_HUMAN Q9V2J8_PYRAB OX1R_HUMAN human OX1R fusion protein to P.abysii glycogen syn..

6to7[2] C SUV
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,.. A 11.8
/29.0 17
/17 OX1R_HUMAN Orexin receptor type 1

6tpj[2] D SUV
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,.. A 10.5
/29.3 19
/19 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6b73[2] E CVV
N-[(5alpha,6beta)-17-(cyclopropylmethyl)-3-hydroxy.. A 50.0
/28.9 8
/15 C562_ECOLX OPRK_HUMAN Soluble cytochrome b562, kappa-type opioid recepto..

8dzr[1] F U9I
methyl (3R)-4-[(3,4-dichlorophenyl)acetyl]-3-[(pyr.. A 57.1
/30.8 7
/11 OPRK_HUMAN Kappa-type opioid receptor

8dzs[1] F U9I
methyl (3R)-4-[(3,4-dichlorophenyl)acetyl]-3-[(pyr.. A 62.5
/29.2 8
/14 OPRK_HUMAN Kappa-type opioid receptor

4dkl[2] B BF0
methyl 4-{[(5beta,6alpha)-17-(cyclopropylmethyl)-3.. A 16.7
/29.2 6
/14 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

3uon[1] B QNB
(3R)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl).. A 18.2
/29.8 11
/17 ACM2_HUMAN LYS_BPT4 ACM2_HUMAN Human M2 muscarinic acetylcholine, receptor T4 lys..

5zk3[1] B QNB
(3R)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl).. A 16.7
/29.2 12
/17 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Apo-cytochrom..

5yc8[3] B 3C0
N-methyl scopolamine[23 atoms] A 12.5
/29.2 8
/14 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Redesigned ap..

5zkb[1] B 82F
N-[2-[(2S)-2-[(dipropylamino)methyl]piperidin-1-yl.. A 16.7
/29.2 12
/19 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Apo-cytochrom..

7sqo[1] J A6F
methyl (2R,3S)-3-[(methanesulfonyl)amino]-2-({[(1s.. A 25.0
/30.4 8
/14 OX2R_HUMAN Orexin receptor type 2

7sr8[1] F A6F
methyl (2R,3S)-3-[(methanesulfonyl)amino]-2-({[(1s.. E 15.4
/29.2 13
/13 Q548Y0_HUMAN Hypocretin receptor type 2

6tp6[2] C NT5
[(2~{R},5~{R})-5-[(5-fluoranylpyridin-2-yl)oxymeth.. A 11.1
/29.1 18
/18 OX1R_HUMAN Orexin receptor type 1

6tq6[1] L NVH
2-(5-methylsulfonylpyridin-3-yl)-1,1-bis(oxidanyli.. B 13.3
/29.1 15
/15 OX1R_HUMAN Orexin receptor type 1

6tq7[1] C NVK
1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyrid.. A 15.4
/29.1 13
/13 OX1R_HUMAN Orexin receptor type 1

6tq7[1] D NVK
1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyrid.. A 9.1
/29.1 11
/11 OX1R_HUMAN Orexin receptor type 1

3odu[9] C ITD
(6,6-dimethyl-5,6-dihydroimidazo[2,1-b][1,3]thiazo.. A 42.9
/30.2 7
/12 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

7l1v[1] G XGD
4'-methoxy-N,N-dimethyl-3'-{[3-(2-{[2-(2H-1,2,3-tr.. E 14.3
/29.1 21
/22 Q548Y0_HUMAN Hypocretin receptor type 2

8dzp[2] F U99
methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-2-(furan-3-yl).. A 60.0
/28.9 10
/18 OPRK_HUMAN Kappa-type opioid receptor

8hnn[1] C 43I
3-azanyl-6-chloranyl-5-[(3S)-4-[1-[(4-chlorophenyl.. B 22.2
/28.9 9
/9 C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t..

5wqc[3] B 7MA
N-ethyl-2-[(6-methoxypyridin-3-yl)-(2-methylphenyl.. A 11.8
/27.1 17
/17 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

6tod[2] C 7MA
N-ethyl-2-[(6-methoxypyridin-3-yl)-(2-methylphenyl.. A 11.1
/28.6 18
/18 OX1R_HUMAN Orexin receptor type 1

7yit[1] D IVB
nalfurafine[35 atoms] A 50.0
/28.9 10
/19 OPRK_HUMAN Kappa-type opioid receptor

2vt4[35] G SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] A 33.3
/31.7 9
/9 ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR

2vt4[3] H SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] A 0.0
/31.7 7
/7 ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR

2vt4[13] I SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] A 25.0
/31.7 12
/12 ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR

2vt4[25] M SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] A 0.0
/31.7 2
/2 ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR

2ycx[2] E SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] B 0.0
/31.0 6
/6 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

6to7[19] F SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] A 25.0
/29.0 4
/4 OX1R_HUMAN Orexin receptor type 1

6to7[36] G SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] A 0.0
/29.0 5
/5 OX1R_HUMAN Orexin receptor type 1

6to7[4] N SOG
octyl 1-thio-beta-D-glucopyranoside[16 atoms] A 50.0
/29.0 4
/6 OX1R_HUMAN Orexin receptor type 1

6to7[2] P SOG
octyl 1-thio-beta-D-glucopyranoside[9 atoms] A 0.0
/29.0 1
/2 OX1R_HUMAN Orexin receptor type 1

6to7[2] Q SOG
octyl 1-thio-beta-D-glucopyranoside[8 atoms] A 25.0
/29.0 4
/5 OX1R_HUMAN Orexin receptor type 1

6to7[13] IA SOG
octyl 1-thio-beta-D-glucopyranoside[16 atoms] B 22.2
/29.3 9
/10 OX1R_HUMAN Orexin receptor type 1

6to7[1] TA SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] B 0.0
/29.3 2
/2 OX1R_HUMAN Orexin receptor type 1

6to7[3] XA SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] B 42.9
/29.3 7
/7 OX1R_HUMAN Orexin receptor type 1

6tod[2] DA SOG
octyl 1-thio-beta-D-glucopyranoside[7 atoms] A 20.0
/28.6 5
/5 OX1R_HUMAN Orexin receptor type 1

6tod[2] EB SOG
octyl 1-thio-beta-D-glucopyranoside[7 atoms] B 100.0
/29.7 2
/6 OX1R_HUMAN Orexin receptor type 1

6tod[1] WA SOG
octyl 1-thio-beta-D-glucopyranoside[9 atoms] B 0.0
/29.7 3
/3 OX1R_HUMAN Orexin receptor type 1

6tos[1] LA SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] B 50.0
/28.9 4
/4 OX1R_HUMAN Orexin receptor type 1

6tq7[1] J SOG
octyl 1-thio-beta-D-glucopyranoside[7 atoms] A 66.7
/29.1 3
/3 OX1R_HUMAN Orexin receptor type 1

6tq9[1] S SOG
octyl 1-thio-beta-D-glucopyranoside[20 atoms] B 50.0
/28.9 2
/2 OX1R_HUMAN Orexin receptor type 1

6tos[2] C NRE
[(2~{S},5~{S})-2-[[(5-bromanylpyridin-2-yl)amino]m.. A 13.3
/29.4 15
/15 OX1R_HUMAN Orexin receptor type 1

6tq9[3] C NVN
1-[6,8-bis(fluoranyl)-2-methyl-quinolin-4-yl]-3-[4.. A 14.3
/29.6 14
/14 OX1R_HUMAN Orexin receptor type 1

6tpn[1] B NU8
2-(5,6-dimethoxypyridin-3-yl)-1,1-bis(oxidanyliden.. A 17.6
/28.8 17
/17 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

7scg[1] F 8RI
(2E)-N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl).. C 40.0
/28.8 10
/10 OPRM_MOUSE Mu-type opioid receptor

7t2h[1] F EID
Lofentanil[30 atoms] E 23.1
/28.8 13
/13 OPRM_MOUSE Mu-type opioid receptor

7u2k[1] E KZR
N-(6-carbamimidamidohexyl)-N-[1-(2-phenylethyl)pip.. C 56.2
/28.8 16
/16 OPRM_MOUSE Mu-type opioid receptor

7u2l[1] F L0X
N-(5-carbamimidamidopentyl)-N-[1-(2-phenylethyl)pi.. D 44.4
/28.8 18
/18 OPRM_MOUSE Mu-type opioid receptor

8k9l[1] G VV9
(2~{S})-2-(3-bromanyl-4-methoxy-phenyl)-3-(4-chlor.. A 12.5
/28.8 8
/9 OPRM_HUMAN Soluble cytochrome b562,Mu-type opioid receptor,Mu..

6tq4[1] P NV8
2-[1-(phenylsulfonyl)-1,8-diazaspiro[4.5]decan-8-y.. B 13.3
/28.7 15
/15 OX1R_HUMAN Orexin receptor type 1

7t2g[1] E EIG
Mitragynine pseudoindoxyl[30 atoms] D 23.1
/28.5 13
/13 C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor

4djh[3] C JDC
(3R)-7-hydroxy-N-{(2S)-1-[(3R,4R)-4-(3-hydroxyphen.. A 45.5
/27.5 11
/20 OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme

6vi4[2] E JDC
(3R)-7-hydroxy-N-{(2S)-1-[(3R,4R)-4-(3-hydroxyphen.. A 50.0
/28.4 8
/13 OPRK_HUMAN Kappa opioid receptor

8hnl[1] H 4AI
(3S)-N-[(2S)-5-carbamimidamido-1-(cyclohexylmethyl.. D 0.0
/28.4 13
/15 C562_ECOLX CXCR3_HUMAN LUCI_OPLGR Soluble cytochrome b562,C-X-C chemokine receptor t..

8hnm[1] H 4IE
[4-(2-bromophenyl)phenyl]methyl-[[(1R,5S)-6,6-dime.. D 11.1
/28.4 9
/10 C562_ECOLX CXCR3_HUMAN LUCI_OPLGR Soluble cytochrome b562,C-X-C chemokine receptor t..

7sbf[1] F 8QY
N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propy.. E 27.3
/29.0 11
/11 C562_ECOLX OPRM_MOUSE Soluble cytochrome b562, Mu-type opioid receptor c..

8efo[2] H 8QY
N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propy.. A 25.0
/28.4 12
/12 OPRM_HUMAN Mu-type opioid receptor

7ul4[1] C NG0
N-[(2S)-2-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimeth.. A 20.0
/28.4 10
/10 OPRM_MOUSE Mu-type opioid receptor

8ef6[2] H MOI
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-.. A 16.7
/28.4 6
/6 OPRM_HUMAN Mu-type opioid receptor

8efb[1] F WH2
N-[(3-methoxythiophen-2-yl)methyl]-2-[(9R)-9-(pyri.. A 40.0
/28.4 15
/15 OPRM_HUMAN Mu-type opioid receptor

8efl[2] H WH9
5,6-dichloro-1-{1-[(4-chlorophenyl)methyl]piperidi.. A 33.3
/28.4 12
/12 OPRM_HUMAN Mu-type opioid receptor

7ran[1] F 3IQ
(3R)-3-methyl-5-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,.. A 33.3
/28.4 9
/9 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A

8ef5[2] H 7V7
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propan.. A 38.5
/28.4 13
/13 OPRM_HUMAN Mu-type opioid receptor

6v9s[1] B JHC
[(2S)-2-[(2S)-butan-2-yl]-4-(5-chloro-1,3-benzoxaz.. A 15.4
/28.3 13
/13 OX1R_HUMAN Q9V2J8_PYRAB OX1R_HUMAN Orexin receptor type 1,GlgA glycogen synthase chim..

6tot[3] C NRK
(1~{R},2~{S})-2-[(2,4-dimethylpyrimidin-5-yl)oxyme.. A 6.2
/29.5 16
/16 OX1R_HUMAN Orexin receptor type 1

6drx[1] B H8G
N,N-diethyl-N'-[(8alpha)-6-methyl-9,10-didehydroer.. A 9.1
/27.9 11
/17 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5HT2B receptor, BRIL chimera

7wc7[1] M H8G
N,N-diethyl-N'-[(8alpha)-6-methyl-9,10-didehydroer.. A 31.2
/28.1 16
/16 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

8uwl[1] F H8G
N,N-diethyl-N'-[(8alpha)-6-methyl-9,10-didehydroer.. A 14.3
/28.2 7
/7 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A

7voe[1] J 9SC
7-[4-[4-[2,3-bis(chloranyl)phenyl]piperazin-1-yl]b.. A 31.2
/28.2 16
/16 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7wc5[1] G 91Q
3-[2-(dimethylamino)ethyl]-1~{H}-indol-4-ol[15 ato.. A 28.6
/28.2 7
/7 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A

6tp3[1] C NS2
[(2~{S})-2-(6-chloranyl-7-methyl-1~{H}-benzimidazo.. A 17.6
/28.2 17
/17 OX1R_HUMAN Orexin receptor type 1

5c1m[2] I VF1
(2R,3S,3aR,5aR,6R,11bR,11cS)-3a-methoxy-3,14-dimet.. A 25.0
/28.1 12
/14 OPRM_MOUSE Mu-type opioid receptor

6dry[1] B H8D
(8beta)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-9,10.. A 11.1
/28.1 9
/16 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5HT2B receptor, BRIL chimera

5tvn[1] B 7LD
(8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoli.. A 10.0
/28.5 10
/18 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

6wgt[3] D 7LD
(8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoli.. A 40.0
/26.1 10
/10 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7srq[3] C 7LD
(8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoli.. A 0.0
/33.6 4
/8 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B

7wc6[1] F 7LD
(8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoli.. A 29.4
/28.1 17
/17 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7vod[1] I 7RU
3-[4-[2-[4-[2,3-bis(chloranyl)phenyl]piperazin-1-y.. A 28.6
/28.1 14
/14 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7wc9[1] G 93F
(10~{R},15~{S})-12-[3-(2-methoxyphenyl)propyl]-4-m.. A 38.5
/28.1 13
/13 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

8jt8[1] C EZX
1-(4-fluorophenyl)-4-[(7R)-2,5,11-triazatetracyclo.. A 31.6
/28.1 19
/19 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7wc8[1] H 92S
1-(4-fluorophenyl)-4-[(10~{R},15~{S})-4-methyl-1,4.. A 31.6
/28.0 19
/19 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

8u4p[1] F VH6
Plerixafor[36 atoms] D 12.5
/28.0 8
/10 CXCR4_HUMAN C-X-C chemokine receptor type 4

6drz[1] G H8J
(8alpha)-N-[(2S)-1-hydroxybutan-2-yl]-1,6-dimethyl.. A 12.5
/28.0 8
/16 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5HT2B receptor, BRIL chimera

7xn9[1] C GI9
tert-butyl (2S)-6-azanyl-2-[[(2R,3S)-3-(1H-indol-3.. A 20.0
/28.0 10
/23 SSR2_HUMAN XYNA_NIACI SSR2_HUMAN Somatostatin receptor type 2,Endo-1,4-beta-xylanas..

7wc4[1] J SRO
SEROTONIN[13 atoms] A 28.6
/27.9 7
/7 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

6a93[2] C 8NU
3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin.. A 25.0
/27.6 16
/16 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6a94[2] C ZOT
2-(3-chloranylbenzo[b][1]benzothiepin-5-yl)oxy-N,N.. A 28.6
/27.6 14
/14 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7wig[1] F 9FI
~{N}-[(2~{R})-1-[[(1~{R},3~{S})-3-(aminomethyl)cyc.. A 33.3
/27.8 9
/9 SSR2_HUMAN Somatostatin receptor type 2

3pqr[2] F NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. A 33.3
/21.0 3
/4 OPSD_BOVIN Rhodopsin

7srs[1] G NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. C 0.0
/27.7 2
/2 5-hydroxytryptamine receptor 2B

6ds0[1] E H8M
(1S)-1-[(2-chloro-3,4-dimethoxyphenyl)methyl]-6-me.. A 25.0
/27.7 8
/15 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5HT2B receptor, BRIL chimera

5t1a[1] B 73R
(3S)-1-{(1S,2R,4R)-4-[methyl(propan-2-yl)amino]-2-.. A 20.0
/27.5 5
/15 CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is..

5t1a[1] C VT5
(2~{R})-1-(4-chloranyl-2-fluoranyl-phenyl)-2-cyclo.. A 60.0
/27.5 5
/14 CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is..

4ib4[2] B ERM
Ergotamine[43 atoms] A 18.2
/27.9 11
/25 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

5tud[2] G ERM
Ergotamine[43 atoms] A 22.2
/27.5 9
/22 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B,Soluble cytochrome..

4zud[1] B OLM
Olmesartan[33 atoms] A 11.1
/27.3 9
/13 C562_ECOLX AGTR1_HUMAN AGTR1_HUMAN Chimera protein of Soluble cytochrome b562 and Typ..

7yac[1] F IUD
Paltusotine[34 atoms] D 16.7
/27.2 12
/13 SSR2_HUMAN Somatostatin receptor type 2

7ymj[1] C JGX
Tamsulosin[28 atoms] A 28.6
/26.9 14
/14 alpha1A-adrenergic receptor

4mbs[2] C MRV
4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(pro.. A 22.2
/26.7 18
/19 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a..

6akx[2] E A4R
N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-.. A 16.7
/26.7 12
/13 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin,C-C chemo..

6aky[1] D A4X
4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(pro.. A 22.2
/26.7 18
/19 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin,C-C chemo..

6wh4[3] D 89F
1-methyl-4-[(5~{S})-3-methylsulfanyl-5,6-dihydrobe.. A 28.6
/26.0 14
/14 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wh4[1] P NDS
ETHYL DIMETHYL AMMONIO PROPANE SULFONATE[12 atoms].. C 0.0
/26.6 2
/3 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

2ycw[2] C CAU
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)pro.. A 40.0
/31.0 15
/15 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4gbr[1] C CAU
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)pro.. A 31.2
/25.2 16
/16 ADRB2_HUMAN Beta-2 adrenergic receptor

5jqh[2] E CAU
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)pro.. A 29.4
/25.1 17
/17 ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor

7bvq[2] E CAU
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)pro.. A 35.3
/26.4 17
/17 D9IEF7_BPT4 Endolysin,Beta-1 adrenergic receptor chimera

3sn6[3] F P0G
8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]a.. D 29.4
/26.1 17
/17 ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor

6ni3[1] F P0G
8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]a.. D 20.0
/26.1 15
/16 A0A097J809_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor chimera

4yay[1] B ZD7
5,7-diethyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl.. A 0.0
/25.6 9
/14 C562_ECOLX AGTR1_HUMAN Soluble cytochrome b562,Type-1 angiotensin II rece..

5zbq[1] B 9AO
N~2~-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-.. A 16.7
/25.4 18
/20 NPY1R_HUMAN A0A097J792_BPT4 Neuropeptide Y receptor type 1,T4 Lysozyme

7xka[1] C G1I
(5R,6R)-6-(methylamino)-5,6,7,8-tetrahydronaphthal.. A 33.3
/25.1 12
/12 ENLYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor

8gdz[31] E G1I
(5R,6R)-6-(methylamino)-5,6,7,8-tetrahydronaphthal.. D 22.2
/25.4 9
/9 ADRB2_HUMAN Beta-2 adrenergic receptor

6hll[1] B GBK
(2~{S},3~{S})-~{N}-[(2-methoxyphenyl)methyl]-2-phe.. A 16.7
/25.3 6
/8 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,GlgA glycogen synthase,Substa..

6hlp[1] B GAW
2-[3,5-bis(trifluoromethyl)phenyl]-~{N},2-dimethyl.. A 30.0
/25.3 10
/17 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6mxt[1] C K5Y
salmeterol[30 atoms] A 26.3
/25.3 19
/20 D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera

7ddz[1] B H46
~{N}-[4-[4-[(1~{S})-2-(diethylamino)-2-oxidanylide.. A 15.4
/25.3 13
/19 A0A097J809_BPT4 NPY2R_HUMAN FLAV_DESVH NPY2R_HUMAN Human Neuropeptide Y Y2 Receptor fusion protein

4ldl[1] C XQC
4-[(1R)-1-hydroxy-2-{[1-(4-hydroxyphenyl)-2-methyl.. A 33.3
/25.1 15
/16 LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor

4ldo[1] D ALE
L-EPINEPHRINE[13 atoms] A 36.4
/25.1 11
/11 LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor

4qkx[1] E 35V
4-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(2-sulfanylet.. A 23.1
/25.1 13
/14 D9IEF7_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor

6n48[1] E KBY
N-[(3R)-4-(4-tert-butylphenyl)-3-({2-[(4-methoxyph.. A 22.2
/25.1 9
/9 A0A097J809_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor,Beta-2 adrene..

7xk9[1] C GJ6
(5R,6R)-6-(propan-2-ylamino)-5,6,7,8-tetrahydronap.. A 30.8
/25.1 13
/13 ENLYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor

6gps[1] C F7N
[(3~{S},4~{S})-3-methoxyoxan-4-yl]-[(1~{R},3~{S})-.. A 9.1
/24.2 11
/17 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6gpx[1] O F7N
[(3~{S},4~{S})-3-methoxyoxan-4-yl]-[(1~{R},3~{S})-.. A 8.3
/25.0 12
/16 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

4xnw[2] C 2ID
[(1R,2S,4S,5S)-4-[2-iodo-6-(methylamino)-9H-purin-.. A 18.2
/24.8 11
/17 P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1,Rubredoxin,P2Y purinoceptor 1

6ibl[2] E H98
~{N}-[5-[(1~{R})-2-[[(2~{R})-1-(4-methoxyphenyl)pr.. A 35.3
/32.2 17
/19 THIO_ECOLI ADRB1_MELGA Thioredoxin 1,Beta-1 adrenergic receptor

6tko[1] E H98
~{N}-[5-[(1~{R})-2-[[(2~{R})-1-(4-methoxyphenyl)pr.. A 33.3
/30.3 15
/16 ADRB1_MELGA Beta-1 adrenergic receptor

7bz2[1] F H98
~{N}-[5-[(1~{R})-2-[[(2~{R})-1-(4-methoxyphenyl)pr.. E 25.0
/24.7 12
/12 Beta2 adrenergic receptor

6e59[1] B L76
1-(4-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl).. A 27.3
/23.6 11
/16 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor, GlgA glycogen synthase, Subs..

5zbh[1] B 9AF
dimethyl 4-{3-[({3-[4-(3-methoxyphenyl)piperidin-1.. A 22.2
/23.6 9
/23 NPY1R_HUMAN D9IEF7_BPT4 NPY1R_HUMAN Neuropeptide Y receptor type 1,T4 Lysozyme,Neurope..

6hlo[1] B GBQ
5-[[(2~{R},3~{S})-2-[(1~{R})-1-[3,5-bis(trifluorom.. A 31.2
/25.3 16
/22 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,GlgA glycogen synthase,Substa..

6j20[2] B GBQ
5-[[(2~{R},3~{S})-2-[(1~{R})-1-[3,5-bis(trifluorom.. A 33.3
/22.9 15
/20 NK1R_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 NK1R_HUMAN Substance-P receptor,Endolysin

1hzx[6] JA HTO
HEPTANE-1,2,3-TRIOL[10 atoms] A 0.0
/21.9 1
/4 OPSD_BOVIN RHODOPSIN

1hzx[2] V HTO
HEPTANE-1,2,3-TRIOL[10 atoms] A 0.0
/21.9 2
/4 OPSD_BOVIN RHODOPSIN

1hzx[1] W HTO
HEPTANE-1,2,3-TRIOL[10 atoms] A 33.3
/21.9 3
/4 OPSD_BOVIN RHODOPSIN

1hzx[2] X HTO
HEPTANE-1,2,3-TRIOL[10 atoms] A 40.0
/21.9 5
/5 OPSD_BOVIN RHODOPSIN

1hzx[2] Y HTO
HEPTANE-1,2,3-TRIOL[10 atoms] A 33.3
/21.9 3
/3 OPSD_BOVIN RHODOPSIN

1u19[5] BA HTO
HEPTANE-1,2,3-TRIOL[10 atoms] B 0.0
/21.3 3
/3 OPSD_BOVIN Rhodopsin

1u19[13] R HTG
heptyl 1-thio-beta-D-glucopyranoside[19 atoms] A 37.5
/21.3 8
/8 OPSD_BOVIN Rhodopsin

1u19[5] FA HTG
heptyl 1-thio-beta-D-glucopyranoside[19 atoms] B 33.3
/21.3 6
/6 OPSD_BOVIN Rhodopsin

2g87[6] EA HTG
heptyl 1-thio-beta-D-glucopyranoside[19 atoms] A 16.7
/21.3 6
/6 OPSD_BOVIN Rhodopsin

2g87[4] FA HTG
heptyl 1-thio-beta-D-glucopyranoside[19 atoms] A 0.0
/21.3 2
/2 OPSD_BOVIN Rhodopsin

3oax[2] T ID3
(3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en.. A 0.0
/21.3 4
/4 OPSD_BOVIN Rhodopsin

5te5[1] B 7AB
(2E)-{(4E)-4-[(3E)-4-(2,6,6-trimethylcyclohex-1-en.. A 20.0
/21.3 15
/15 OPSD_BOVIN Rhodopsin

1gzm[27] G RET
RETINAL[20 atoms] A 18.8
/21.0 16
/16 OPSD_BOVIN RHODOPSIN

1hzx[4] G BNG
nonyl beta-D-glucopyranoside[21 atoms] A 16.7
/21.9 6
/6 OPSD_BOVIN RHODOPSIN

1hzx[2] I BNG
nonyl beta-D-glucopyranoside[21 atoms] A 40.0
/21.9 5
/5 OPSD_BOVIN RHODOPSIN

1hzx[2] J BNG
nonyl beta-D-glucopyranoside[21 atoms] A 25.0
/21.9 8
/8 OPSD_BOVIN RHODOPSIN

1hzx[2] K BNG
nonyl beta-D-glucopyranoside[21 atoms] A 0.0
/21.9 4
/8 OPSD_BOVIN RHODOPSIN

1hzx[2] Z BNG
nonyl beta-D-glucopyranoside[21 atoms] A 0.0
/21.9 1
/1 OPSD_BOVIN RHODOPSIN

4x1h[1] E BNG
nonyl beta-D-glucopyranoside[21 atoms] A 14.3
/21.0 14
/14 OPSD_BOVIN Rhodopsin

4x1h[1] F BNG
nonyl beta-D-glucopyranoside[21 atoms] A 50.0
/21.0 6
/6 OPSD_BOVIN Rhodopsin

3cap[1] I BGL
2-O-octyl-beta-D-glucopyranose[20 atoms] A 0.0
/21.0 5
/5 OPSD_BOVIN Rhodopsin

3cap[2] J BGL
2-O-octyl-beta-D-glucopyranose[20 atoms] A 0.0
/21.0 2
/2 OPSD_BOVIN Rhodopsin

3cap[1] M BGL
2-O-octyl-beta-D-glucopyranose[20 atoms] B 0.0
/21.0 1
/2 OPSD_BOVIN Rhodopsin

6pel[1] D ODM
(3R)-3,7-dimethyloct-6-en-1-ol[11 atoms] A 10.0
/21.0 10
/10 OPSD_BOVIN Rhodopsin

6pgs[1] F 64Z
Geraniol[11 atoms] A 20.0
/21.0 10
/10 OPSD_BOVIN Rhodopsin

6ph7[2] F NZZ
(2Z)-3,7-dimethylocta-2,6-dien-1-ol[11 atoms] A 18.2
/21.0 11
/11 OPSD_BOVIN Rhodopsin

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

METAL

424 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

6mxt[1] D MG
MAGNESIUM ION[1 atoms] A 33.3
/25.3 3
/5 D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera

7ryc[1] F MG
MAGNESIUM ION[1 atoms] B 100.0
/63.9 2
/2 OXYR_HUMAN Oxytocin receptor

9bkj[1] F NH2
AMINO GROUP[1 atoms] D 0.0
/33.2 2
/2 CCKAR_HUMAN Cholecystokinin receptor type A

1hzx[15] L HG
MERCURY (II) ION[1 atoms] A 40.0
/21.9 5
/5 OPSD_BOVIN RHODOPSIN

1hzx[15] M HG
MERCURY (II) ION[1 atoms] A 75.0
/21.9 4
/4 OPSD_BOVIN RHODOPSIN

1hzx[15] N HG
MERCURY (II) ION[1 atoms] A 0.0
/21.9 3
/3 OPSD_BOVIN RHODOPSIN

5yc8[2] C HG
MERCURY (II) ION[1 atoms] A 0.0
/29.2 2
/2 ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Redesigned ap..

3uon[1] E CL
CHLORIDE ION[1 atoms] A 0.0
/29.8 2
/3 ACM2_HUMAN LYS_BPT4 ACM2_HUMAN Human M2 muscarinic acetylcholine, receptor T4 lys..

6do1[2] J CL
CHLORIDE ION[1 atoms] A 0.0
/26.9 2
/2 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome ..

6do1[1] K CL
CHLORIDE ION[1 atoms] A 100.0
/26.9 1
/1 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome ..

6tp6[1] L CL
CHLORIDE ION[1 atoms] A 0.0
/29.1 1
/2 OX1R_HUMAN Orexin receptor type 1

1gzm[3] R ZN
ZINC ION[1 atoms] A 0.0
/21.0 5
/5 OPSD_BOVIN RHODOPSIN

1hzx[15] O ZN
ZINC ION[1 atoms] A 0.0
/21.9 3
/3 OPSD_BOVIN RHODOPSIN

1hzx[10] P ZN
ZINC ION[1 atoms] A 33.3
/21.9 6
/6 OPSD_BOVIN RHODOPSIN

1hzx[15] Q ZN
ZINC ION[1 atoms] A 16.7
/21.9 6
/6 OPSD_BOVIN RHODOPSIN

1hzx[1] R ZN
ZINC ION[1 atoms] A 60.0
/21.9 5
/5 OPSD_BOVIN RHODOPSIN

1l9h[16] R ZN
ZINC ION[1 atoms] A 0.0
/21.9 1
/3 OPSD_BOVIN rhodopsin

2g87[4] K ZN
ZINC ION[1 atoms] B 0.0
/21.3 1
/1 OPSD_BOVIN Rhodopsin

4mbs[6] D ZN
ZINC ION[1 atoms] A 0.0
/26.7 4
/4 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a..

4xnw[2] D ZN
ZINC ION[1 atoms] A 0.0
/24.8 4
/4 P2RY1_HUMAN RUBR_CLOPA P2RY1_HUMAN P2Y purinoceptor 1,Rubredoxin,P2Y purinoceptor 1

5t1a[1] I ZN
ZINC ION[1 atoms] A 50.0
/27.5 2
/4 CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is..

5vbl[3] C ZN
ZINC ION[1 atoms] B 0.0
/27.9 4
/4 APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor,Rubredoxin,Apelin receptor Chimera..

6gps[1] B ZN
ZINC ION[1 atoms] A 0.0
/24.2 5
/5 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6gpx[1] C ZN
ZINC ION[1 atoms] A 0.0
/25.0 4
/4 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6me6[4] D ZN
ZINC ION[1 atoms] A 0.0
/28.8 2
/4 C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B..

7f1t[1] B ZN
ZINC ION[1 atoms] A 0.0
/26.7 5
/5 CCL3_HUMAN CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C motif chemokine 3,C-C chemokine receptor type ..

6mxt[1] E NI
NICKEL (II) ION[1 atoms] A 0.0
/25.3 2
/2 D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera

2vt4[21] F NA
SODIUM ION[1 atoms] A 100.0
/31.7 2
/3 ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR

3zpq[5] R NA
SODIUM ION[1 atoms] B 100.0
/31.5 2
/2 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4lde[6] D NA
SODIUM ION[1 atoms] A 33.3
/25.1 3
/5 LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor

4n6h[1] U NA
SODIUM ION[1 atoms] A 66.7
/32.4 3
/3 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

6h7j[10] H NA
SODIUM ION[1 atoms] B 66.7
/32.0 3
/4 ADRB1_MELGA Beta-1 adrenergic receptor

6ibl[2] F NA
SODIUM ION[1 atoms] A 66.7
/32.2 3
/4 THIO_ECOLI ADRB1_MELGA Thioredoxin 1,Beta-1 adrenergic receptor

6to7[5] CA NA
SODIUM ION[1 atoms] A 66.7
/29.0 3
/3 OX1R_HUMAN Orexin receptor type 1

7bvq[1] M NA
SODIUM ION[1 atoms] A 100.0
/26.4 2
/3 D9IEF7_BPT4 Endolysin,Beta-1 adrenergic receptor chimera

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

OTHERPOLY

424 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

7f9z[1] C 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE.. G 50.0
/35.3 8
/17 human ghrelin receptor

1gzm[2] D beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 50.0
/21.0 2
/4 OPSD_BOVIN RHODOPSIN

3c9l[1] C beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A 50.0
/21.0 2
/3 OPSD_BOVIN Rhodopsin

1hzx[22] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. A 33.3
/21.9 3
/5 OPSD_BOVIN RHODOPSIN

3pqr[6] D alpha-D-glucopyranose-(1-1)-alpha-D-glucopyranose A 20.0
/21.0 5
/5 OPSD_BOVIN Rhodopsin

4x1h[1] D 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-a.. A 33.3
/21.0 3
/4 OPSD_BOVIN Rhodopsin

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

HOMO

424 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

5unf[2] B C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor .. A 25.0
/34.7 16
/18 C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor ..

5unf[2] A C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor .. B 33.3
/33.3 6
/19 C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor ..

6pt2[2] B Delta opioid receptor[361 aa] A 0.0
/31.5 5
/22 Delta opioid receptor

8f7s[2] F OPRD_HUMAN Delta-type opioid receptor[289 aa] A 20.0
/32.2 25
/27 OPRD_HUMAN Delta-type opioid receptor

6me6[1] A C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B.. B 20.0
/32.2 5
/15 C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B..

4ea3[1] A C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. B 16.7
/33.9 6
/7 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

4ea3[3] A C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. B 35.7
/33.9 14
/14 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

4ea3[1] A C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. B 44.4
/33.9 9
/20 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

6pt2[2] A Delta opioid receptor[397 aa] B 42.9
/31.6 7
/16 Delta opioid receptor

7f83[1] B GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl.. A 100.0
/32.6 4
/14 GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl..

7f83[1] A GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl.. B 38.5
/31.3 13
/16 GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl..

2vt4[14] B ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR[276 aa] A 9.1
/31.7 11
/11 ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR

4gpo[2] B ADRB1_MELGA Beta-1 adrenergic receptor[280 aa] A 33.3
/31.3 3
/8 ADRB1_MELGA Beta-1 adrenergic receptor

4ea3[1] B C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. A 60.0
/30.9 5
/7 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

4ea3[3] B C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. A 25.0
/30.9 16
/18 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

4ea3[1] B C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. A 43.8
/30.9 16
/16 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

7w0l[4] E C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor[298 aa] D 0.0
/30.1 1
/3 C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor

8th3[1] B AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN AT118-H nanobody, Type-1 angiotensin II receptor, .. A 0.0
/29.8 1
/24 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN AT118-H nanobody, Type-1 angiotensin II receptor, ..

8u4s[7] F CXCR4_HUMAN C-X-C chemokine receptor type 4[284 aa] C 23.5
/28.4 17
/19 CXCR4_HUMAN C-X-C chemokine receptor type 4

8u4s[7] I CXCR4_HUMAN C-X-C chemokine receptor type 4[284 aa] C 23.1
/28.4 13
/16 CXCR4_HUMAN C-X-C chemokine receptor type 4

4dkl[2] A OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera[442 aa] A 23.1
/29.2 13
/29 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

3odu[9] B CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera[.. A 0.0
/30.2 3
/23 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3oe8[1] B CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera[.. A 0.0
/28.0 6
/14 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3oe8[1] A CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera[.. B 0.0
/28.6 5
/13 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

6me6[1] B C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B.. A 33.3
/28.8 6
/11 C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B..

6vi4[2] B OPRK_HUMAN Kappa opioid receptor[276 aa] A 33.3
/28.4 3
/12 OPRK_HUMAN Kappa opioid receptor

8ef5[8] F OPRM_HUMAN Mu-type opioid receptor[288 aa] A 20.0
/28.4 10
/11 OPRM_HUMAN Mu-type opioid receptor

8f7q[4] G OPRM_HUMAN Mu-type opioid receptor[287 aa] A 18.2
/28.4 11
/12 OPRM_HUMAN Mu-type opioid receptor

4djh[2] B OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme[448 aa] A 30.0
/27.5 10
/19 OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme

4djh[2] B OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme[448 aa] A 33.3
/27.5 15
/16 OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme

1gzm[2] B OPSD_BOVIN RHODOPSIN[330 aa] A 12.5
/21.0 16
/17 OPSD_BOVIN RHODOPSIN

1hzx[10] B OPSD_BOVIN RHODOPSIN[302 aa] A 20.0
/21.9 10
/17 OPSD_BOVIN RHODOPSIN

1hzx[8] B OPSD_BOVIN RHODOPSIN[302 aa] A 33.3
/21.9 3
/8 OPSD_BOVIN RHODOPSIN

3cap[12] B OPSD_BOVIN Rhodopsin[326 aa] A 0.0
/21.0 2
/7 OPSD_BOVIN Rhodopsin

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

PRECIPITANT

424 pdb_id contact mol homologue

a³ description a⁴ identity[%]⁵ Ncon⁶ description

7jni[1] J FMT
FORMIC ACID[3 atoms] A 77.8
/34.3 9
/9 C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece..

4n6h[2] N PGE
TRIETHYLENE GLYCOL[10 atoms] A 0.0
/32.4 3
/3 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4n6h[1] O PGE
TRIETHYLENE GLYCOL[10 atoms] A 0.0
/32.4 1
/1 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4n6h[1] S TLA
L(+)-TARTARIC ACID[10 atoms] A 28.6
/32.4 7
/7 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

2y00[48] E 2CV
HEGA-10[26 atoms] A 14.3
/32.3 7
/7 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

2y00[28] F 2CV
HEGA-10[5 atoms] A 25.0
/32.3 4
/4 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

2y00[10] H 2CV
HEGA-10[26 atoms] A 40.0
/32.3 5
/5 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

2y00[40] I 2CV
HEGA-10[26 atoms] A 0.0
/32.3 2
/2 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

2ycw[2] I 2CV
HEGA-10[10 atoms] B 0.0
/31.0 2
/2 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

3zpr[1] H 2CV
HEGA-10[14 atoms] A 0.0
/31.8 1
/4 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

6h7j[5] I 2CV
HEGA-10[26 atoms] B 28.6
/32.0 7
/7 ADRB1_MELGA Beta-1 adrenergic receptor

6h7j[12] J 2CV
HEGA-10[16 atoms] B 75.0
/32.0 4
/4 ADRB1_MELGA Beta-1 adrenergic receptor

6h7m[2] L 2CV
HEGA-10[26 atoms] E 0.0
/31.7 2
/3 ADRB1_MELGA Beta-1 adrenergic receptor

6ibl[1] G 2CV
HEGA-10[26 atoms] A 25.0
/32.2 8
/8 THIO_ECOLI ADRB1_MELGA Thioredoxin 1,Beta-1 adrenergic receptor

6ibl[2] I 2CV
HEGA-10[24 atoms] A 50.0
/32.2 10
/10 THIO_ECOLI ADRB1_MELGA Thioredoxin 1,Beta-1 adrenergic receptor

6ibl[2] J 2CV
HEGA-10[26 atoms] A 14.3
/32.2 7
/7 THIO_ECOLI ADRB1_MELGA Thioredoxin 1,Beta-1 adrenergic receptor

3oe6[2] F GOL
GLYCEROL[6 atoms] A 33.3
/29.6 6
/8 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

7br3[1] B 1QW
(2R)-2,3-dihydroxypropyl dodecanoate[19 atoms] A 0.0
/29.5 4
/4 GNRHR_HUMAN Q9V2J8_PYRAB GNRHR_HUMAN Gonadotropin-releasing hormone receptor,GlgA glyco..

8k2w[1] D PCW
1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[54 atoms].. B 30.8
/29.4 13
/13 C562_ECOLX CXCR3_HUMAN OPRK_HUMAN CXCR3_HUMAN Soluble cytochrome b562,C-X-C chemokine receptor t..

4dkl[2] P MPG
[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propano.. A 20.0
/29.2 5
/5 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

4dkl[2] Q MPG
[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propano.. A 0.0
/29.2 6
/8 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

3odu[4] G OLA
OLEIC ACID[10 atoms] A 0.0
/30.2 4
/4 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3odu[10] L OLA
OLEIC ACID[20 atoms] B 50.0
/30.2 2
/8 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3odu[1] M OLA
OLEIC ACID[20 atoms] B 50.0
/30.2 8
/8 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3odu[1] N OLA
OLEIC ACID[12 atoms] B 100.0
/30.2 4
/4 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3odu[1] O OLA
OLEIC ACID[13 atoms] B 25.0
/30.2 4
/7 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

4ea3[15] E OLA
OLEIC ACID[20 atoms] A 33.3
/30.9 3
/6 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

4ea3[3] E OLA
OLEIC ACID[20 atoms] B 0.0
/33.9 4
/4 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

4n6h[1] D OLA
OLEIC ACID[15 atoms] A 33.3
/32.4 3
/3 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4n6h[1] E OLA
OLEIC ACID[20 atoms] A 16.7
/32.4 6
/6 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4n6h[8] F OLA
OLEIC ACID[20 atoms] A 57.1
/32.4 7
/7 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4n6h[9] G OLA
OLEIC ACID[9 atoms] A 11.1
/32.4 9
/10 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4n6h[2] K OLA
OLEIC ACID[11 atoms] A 33.3
/32.4 3
/3 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4nc3[2] K OLA
OLEIC ACID[10 atoms] A 100.0
/27.6 1
/1 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

4nc3[1] L OLA
OLEIC ACID[20 atoms] A 100.0
/27.6 1
/5 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

4rwd[1] G OLA
OLEIC ACID[13 atoms] A 0.0
/32.2 1
/1 C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor..

4rwd[8] J OLA
OLEIC ACID[12 atoms] A 0.0
/32.2 1
/5 C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor..

4zj8[4] G OLA
OLEIC ACID[11 atoms] A 0.0
/32.0 2
/2 OX1R_HUMAN Q9V2J8_PYRAB OX1R_HUMAN human OX1R fusion protein to P.abysii glycogen syn..

4zj8[3] H OLA
OLEIC ACID[7 atoms] A 66.7
/32.0 3
/4 OX1R_HUMAN Q9V2J8_PYRAB OX1R_HUMAN human OX1R fusion protein to P.abysii glycogen syn..

5dhg[9] D OLA
OLEIC ACID[6 atoms] A 0.0
/29.8 3
/3 C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor

5dhg[4] I OLA
OLEIC ACID[12 atoms] B 20.0
/33.9 5
/6 C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor

5dhg[2] J OLA
OLEIC ACID[9 atoms] B 50.0
/33.9 2
/4 C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor

5dhh[1] J OLA
OLEIC ACID[7 atoms] A 0.0
/30.8 1
/1 C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor

5uiw[1] J OLA
OLEIC ACID[12 atoms] A 0.0
/26.7 2
/2 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin chimera

5uiw[1] K OLA
OLEIC ACID[8 atoms] A 0.0
/26.7 3
/3 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin chimera

5wqc[4] C OLA
OLEIC ACID[14 atoms] A 0.0
/27.1 1
/1 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

5wqc[3] D OLA
OLEIC ACID[20 atoms] A 0.0
/27.1 4
/4 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

5wqc[2] E OLA
OLEIC ACID[14 atoms] A 57.1
/27.1 7
/7 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

5wqc[3] F OLA
OLEIC ACID[20 atoms] A 25.0
/27.1 8
/8 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

6gpx[1] D OLA
OLEIC ACID[15 atoms] A 50.0
/25.0 6
/6 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6gpx[1] E OLA
OLEIC ACID[12 atoms] A 0.0
/25.0 4
/4 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6gpx[1] H OLA
OLEIC ACID[15 atoms] A 0.0
/25.0 1
/1 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6gpx[1] I OLA
OLEIC ACID[20 atoms] A 16.7
/25.0 6
/10 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6gpx[3] J OLA
OLEIC ACID[9 atoms] A 0.0
/25.0 1
/2 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6gpx[1] K OLA
OLEIC ACID[11 atoms] A 0.0
/25.0 3
/3 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6gpx[1] L OLA
OLEIC ACID[15 atoms] A 20.0
/25.0 10
/10 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6gpx[1] N OLA
OLEIC ACID[20 atoms] A 16.7
/25.0 6
/7 CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo..

6hlo[1] I OLA
OLEIC ACID[9 atoms] A 0.0
/25.3 1
/2 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,GlgA glycogen synthase,Substa..

6hlo[1] J OLA
OLEIC ACID[11 atoms] A 100.0
/25.3 1
/3 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,GlgA glycogen synthase,Substa..

6hlo[1] O OLA
OLEIC ACID[9 atoms] A 0.0
/25.3 1
/1 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,GlgA glycogen synthase,Substa..

6mxt[1] H OLA
OLEIC ACID[20 atoms] A 40.0
/25.3 5
/5 D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera

6pt2[1] F OLA
OLEIC ACID[20 atoms] A 25.0
/31.5 4
/5 Delta opioid receptor

6pt2[2] G OLA
OLEIC ACID[20 atoms] A 33.3
/31.5 9
/9 Delta opioid receptor

6pt2[1] H OLA
OLEIC ACID[13 atoms] B 50.0
/31.6 2
/2 Delta opioid receptor

6pt2[1] K OLA
OLEIC ACID[9 atoms] B 0.0
/31.6 2
/2 Delta opioid receptor

6pt2[1] L OLA
OLEIC ACID[9 atoms] B 0.0
/31.6 3
/3 Delta opioid receptor

6tpj[1] C OLA
OLEIC ACID[8 atoms] A 100.0
/29.3 1
/1 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpj[2] K OLA
OLEIC ACID[8 atoms] A 0.0
/29.3 3
/3 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpj[1] M OLA
OLEIC ACID[6 atoms] A 66.7
/29.3 3
/3 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpj[1] O OLA
OLEIC ACID[15 atoms] A 33.3
/29.3 6
/7 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpj[2] P OLA
OLEIC ACID[14 atoms] A 50.0
/29.3 2
/7 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpj[1] Q OLA
OLEIC ACID[6 atoms] A 33.3
/29.3 3
/3 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpj[1] DA OLA
OLEIC ACID[20 atoms] B 16.7
/29.3 6
/6 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpj[1] EA OLA
OLEIC ACID[7 atoms] B 50.0
/29.3 2
/2 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpj[1] QA OLA
OLEIC ACID[5 atoms] B 0.0
/29.3 1
/2 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpj[1] RA OLA
OLEIC ACID[8 atoms] B 0.0
/29.3 1
/1 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpn[1] J OLA
OLEIC ACID[13 atoms] A 25.0
/28.8 4
/5 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

6wgt[1] F OLA
OLEIC ACID[17 atoms] A 14.3
/26.1 7
/8 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wgt[1] G OLA
OLEIC ACID[20 atoms] A 0.0
/26.1 4
/4 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wgt[2] K OLA
OLEIC ACID[10 atoms] B 0.0
/27.5 3
/3 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wh4[1] E OLA
OLEIC ACID[20 atoms] A 0.0
/26.0 7
/7 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wh4[1] Q OLA
OLEIC ACID[20 atoms] C 16.7
/26.6 6
/8 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7sr8[1] I OLA
OLEIC ACID[13 atoms] E 0.0
/29.2 3
/3 Q548Y0_HUMAN Hypocretin receptor type 2

6to7[1] AA SOG
octyl 1-thio-beta-D-glucopyranoside[4 atoms] A 100.0
/29.0 3
/3 OX1R_HUMAN Orexin receptor type 1

6to7[2] M SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] A 0.0
/29.0 1
/1 OX1R_HUMAN Orexin receptor type 1

6to7[1] R SOG
octyl 1-thio-beta-D-glucopyranoside[5 atoms] A 75.0
/29.0 4
/4 OX1R_HUMAN Orexin receptor type 1

6to7[2] T SOG
octyl 1-thio-beta-D-glucopyranoside[5 atoms] A 25.0
/29.0 4
/4 OX1R_HUMAN Orexin receptor type 1

6to7[1] X SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] A 100.0
/29.0 1
/1 OX1R_HUMAN Orexin receptor type 1

6to7[1] Y SOG
octyl 1-thio-beta-D-glucopyranoside[4 atoms] A 0.0
/29.0 1
/1 OX1R_HUMAN Orexin receptor type 1

6to7[1] Z SOG
octyl 1-thio-beta-D-glucopyranoside[4 atoms] A 0.0
/29.0 1
/1 OX1R_HUMAN Orexin receptor type 1

6to7[2] BB SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] B 0.0
/29.3 1
/1 OX1R_HUMAN Orexin receptor type 1

6to7[1] VA SOG
octyl 1-thio-beta-D-glucopyranoside[4 atoms] B 0.0
/29.3 2
/2 OX1R_HUMAN Orexin receptor type 1

6to7[1] WA SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] B 20.0
/29.3 5
/5 OX1R_HUMAN Orexin receptor type 1

6to7[4] YA SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] B 0.0
/29.3 4
/4 OX1R_HUMAN Orexin receptor type 1

6to7[1] ZA SOG
octyl 1-thio-beta-D-glucopyranoside[5 atoms] B 50.0
/29.3 2
/2 OX1R_HUMAN Orexin receptor type 1

6tod[1] ZA SOG
octyl 1-thio-beta-D-glucopyranoside[5 atoms] B 0.0
/29.7 3
/5 OX1R_HUMAN Orexin receptor type 1

6tos[1] FA SOG
octyl 1-thio-beta-D-glucopyranoside[5 atoms] B 20.0
/28.9 5
/5 OX1R_HUMAN Orexin receptor type 1

6tos[1] IA SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] B 0.0
/28.9 3
/3 OX1R_HUMAN Orexin receptor type 1

6tp6[1] U SOG
octyl 1-thio-beta-D-glucopyranoside[6 atoms] B 50.0
/29.1 2
/2 OX1R_HUMAN Orexin receptor type 1

6tq4[1] V SOG
octyl 1-thio-beta-D-glucopyranoside[5 atoms] B 50.0
/28.7 2
/3 OX1R_HUMAN Orexin receptor type 1

6tq7[2] K SOG
octyl 1-thio-beta-D-glucopyranoside[4 atoms] A 50.0
/29.1 2
/2 OX1R_HUMAN Orexin receptor type 1

6akx[2] D NO3
NITRATE ION[4 atoms] A 50.0
/26.7 6
/6 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin,C-C chemo..

6tpn[1] D NO3
NITRATE ION[4 atoms] A 50.0
/28.8 4
/5 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

8efq[1] F ETA
ETHANOLAMINE[4 atoms] E 0.0
/28.8 1
/1 OPRM_HUMAN Mu-type opioid receptor

1gzm[72] H PLM
PALMITIC ACID[17 atoms] A 100.0
/21.0 2
/5 OPSD_BOVIN RHODOPSIN

1l9h[1] W PLM
PALMITIC ACID[16 atoms] A 100.0
/21.9 1
/3 OPSD_BOVIN rhodopsin

1u19[28] Q PLM
PALMITIC ACID[16 atoms] A 33.3
/21.3 6
/6 OPSD_BOVIN Rhodopsin

4ib4[2] C PLM
PALMITIC ACID[17 atoms] A 0.0
/27.9 1
/5 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

6a93[2] J PLM
PALMITIC ACID[10 atoms] B 33.3
/27.9 3
/3 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6omm[1] M PLM
PALMITIC ACID[18 atoms] A 40.0
/29.8 5
/5 FPR2_HUMAN N-formyl peptide receptor 2

7t6u[3] G PLM
PALMITIC ACID[18 atoms] F 66.7
/29.8 3
/3 FPR2_HUMAN N-formyl peptide receptor 2

8f7s[2] K PLM
PALMITIC ACID[18 atoms] A 66.7
/32.2 3
/3 OPRD_HUMAN Delta-type opioid receptor

8f7s[2] L PLM
PALMITIC ACID[18 atoms] A 50.0
/32.2 4
/4 OPRD_HUMAN Delta-type opioid receptor

8f7s[2] M PLM
PALMITIC ACID[18 atoms] A 66.7
/32.2 3
/3 OPRD_HUMAN Delta-type opioid receptor

8f7s[2] N PLM
PALMITIC ACID[18 atoms] A 100.0
/32.2 1
/2 OPRD_HUMAN Delta-type opioid receptor

8f7s[1] O PLM
PALMITIC ACID[18 atoms] A 12.5
/32.2 8
/8 OPRD_HUMAN Delta-type opioid receptor

8f7s[2] Q PLM
PALMITIC ACID[18 atoms] A 0.0
/32.2 1
/1 OPRD_HUMAN Delta-type opioid receptor

8f7s[2] R PLM
PALMITIC ACID[18 atoms] A 66.7
/32.2 3
/3 OPRD_HUMAN Delta-type opioid receptor

8f7s[2] S PLM
PALMITIC ACID[18 atoms] A 50.0
/32.2 2
/2 OPRD_HUMAN Delta-type opioid receptor

8f7w[1] K PLM
PALMITIC ACID[18 atoms] A 33.3
/28.4 3
/3 OPRK_HUMAN Kappa-type opioid receptor

5c1m[2] F PO4
PHOSPHATE ION[5 atoms] A 50.0
/28.1 2
/3 OPRM_MOUSE Mu-type opioid receptor

6wgt[1] L PO4
PHOSPHATE ION[5 atoms] B 100.0
/27.5 1
/4 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wgt[1] M PO4
PHOSPHATE ION[5 atoms] B 20.0
/27.5 5
/5 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wgt[1] P PO4
PHOSPHATE ION[5 atoms] C 0.0
/24.1 3
/3 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

5c1m[2] G P6G
HEXAETHYLENE GLYCOL[19 atoms] A 0.0
/28.1 6
/7 OPRM_MOUSE Mu-type opioid receptor

5c1m[1] H P6G
HEXAETHYLENE GLYCOL[13 atoms] A 25.0
/28.1 4
/4 OPRM_MOUSE Mu-type opioid receptor

6to7[5] D PG4
TETRAETHYLENE GLYCOL[13 atoms] A 33.3
/29.0 6
/7 OX1R_HUMAN Orexin receptor type 1

6to7[3] FA PG4
TETRAETHYLENE GLYCOL[13 atoms] B 33.3
/29.3 6
/6 OX1R_HUMAN Orexin receptor type 1

6to7[1] GA PG4
TETRAETHYLENE GLYCOL[11 atoms] B 0.0
/29.3 2
/2 OX1R_HUMAN Orexin receptor type 1

6tod[1] G PG4
TETRAETHYLENE GLYCOL[13 atoms] A 25.0
/28.6 4
/4 OX1R_HUMAN Orexin receptor type 1

6tot[1] D PG4
TETRAETHYLENE GLYCOL[13 atoms] A 25.0
/29.5 4
/4 OX1R_HUMAN Orexin receptor type 1

6tp6[2] D PG4
TETRAETHYLENE GLYCOL[13 atoms] A 37.5
/29.1 8
/8 OX1R_HUMAN Orexin receptor type 1

6tpg[4] C PG4
TETRAETHYLENE GLYCOL[13 atoms] A 33.3
/28.9 6
/6 OX2R_HUMAN Q9V2J8_PYRAB Q548Y0_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Hypo..

6tpn[1] F PG4
TETRAETHYLENE GLYCOL[13 atoms] A 100.0
/28.8 1
/2 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

6tq6[1] V PG4
TETRAETHYLENE GLYCOL[13 atoms] B 20.0
/29.1 10
/11 OX1R_HUMAN Orexin receptor type 1

7bvq[1] R PG4
TETRAETHYLENE GLYCOL[13 atoms] A 25.0
/26.4 4
/4 D9IEF7_BPT4 Endolysin,Beta-1 adrenergic receptor chimera

8e0g[1] H PG4
TETRAETHYLENE GLYCOL[13 atoms] A 50.0
/28.1 2
/2 OPRM_MOUSE Mu-type opioid receptor

3odu[1] D OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[18 .. A 33.3
/30.2 3
/3 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3odu[1] E OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[22 .. A 25.0
/30.2 4
/11 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3odu[1] F OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. A 0.0
/30.2 4
/11 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3odu[10] I OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. B 62.5
/30.2 8
/9 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3odu[1] J OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[22 .. B 0.0
/30.2 1
/1 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

3oe6[2] D OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. A 0.0
/29.6 3
/3 CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera

4bvn[2] F OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[20 .. A 37.5
/30.4 8
/8 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4bvn[5] G OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. A 14.3
/30.4 7
/7 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4bvn[1] I OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[11 .. A 16.7
/30.4 6
/6 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4bvn[2] J OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[17 .. A 40.0
/30.4 5
/5 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4bvn[1] K OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. A 50.0
/30.4 4
/4 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4bvn[2] L OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[17 .. A 22.2
/30.4 9
/11 ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR

4djh[11] F OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. A 25.0
/27.5 4
/4 OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme

4djh[1] F OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. B 14.3
/27.5 7
/8 OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme

4djh[3] G OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[21 .. B 50.0
/27.5 8
/9 OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme

4ea3[2] G OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. A 0.0
/30.9 3
/4 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

4ea3[7] G OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. B 28.6
/33.9 7
/7 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

4ib4[2] E OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[19 .. A 28.6
/27.9 7
/10 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

4mbs[1] E OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. A 0.0
/26.7 3
/4 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a..

4mbs[7] F OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. A 0.0
/26.7 4
/4 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a..

4mbs[1] H OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. A 16.7
/26.7 6
/7 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a..

4mbs[13] I OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[19 .. A 16.7
/26.7 6
/9 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a..

4mbs[2] J OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[12 .. A 60.0
/26.7 5
/5 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a..

4mbs[2] O OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. B 66.7
/26.7 3
/3 CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a..

4n6h[1] H OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. A 16.7
/32.4 6
/6 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4n6h[1] I OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[18 .. A 20.0
/32.4 5
/5 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4n6h[1] M OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. A 0.0
/32.4 2
/2 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4n6h[1] W OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[22 .. A 18.2
/32.4 11
/11 C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto..

4nc3[20] H OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. A 66.7
/27.6 3
/3 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

4rwa[2] E OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. A 14.3
/33.3 7
/7 C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor..

4rwd[2] H OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. A 22.2
/32.2 9
/9 C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor..

5c1m[2] C OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. A 0.0
/28.1 2
/2 OPRM_MOUSE Mu-type opioid receptor

5c1m[2] D OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[18 .. A 33.3
/28.1 3
/4 OPRM_MOUSE Mu-type opioid receptor

5ung[3] C OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[14 .. A 0.0
/34.3 1
/4 C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor ..

6do1[2] N OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. A 0.0
/26.9 5
/5 AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome ..

6hlo[1] V OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[10 .. A 0.0
/25.3 3
/3 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,GlgA glycogen synthase,Substa..

6hlo[1] W OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. A 0.0
/25.3 3
/5 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,GlgA glycogen synthase,Substa..

6hlp[4] N OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[23 .. A 50.0
/25.3 6
/6 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6hlp[1] NA OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[17 .. A 50.0
/25.3 2
/6 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6hlp[1] Q OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. A 33.3
/25.3 6
/6 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6j21[1] C OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[19 .. A 33.3
/22.9 3
/9 NK1R_HUMAN D9IEF7_BPT4 D9IEF7_BPT4 NK1R_HUMAN Substance-P receptor,Endolysin

6mxt[1] F OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. A 25.0
/25.3 4
/4 D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera

6pt2[2] M OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[19 .. B 25.0
/31.6 4
/4 Delta opioid receptor

6rz9[1] H OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[8 a.. A 0.0
/31.1 1
/3 CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom..

6rz9[1] K OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[6 a.. A 50.0
/31.1 2
/2 CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom..

6rz9[1] N OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[8 a.. A 100.0
/31.1 1
/1 CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom..

6rz9[1] O OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[11 .. A 50.0
/31.1 4
/4 CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom..

7br3[1] D OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[12 .. A 66.7
/29.5 3
/3 GNRHR_HUMAN Q9V2J8_PYRAB GNRHR_HUMAN Gonadotropin-releasing hormone receptor,GlgA glyco..

7f83[1] F OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[19 .. A 25.0
/32.6 4
/5 GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl..

7f83[1] I OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. A 66.7
/32.6 3
/6 GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl..

7f83[2] C OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[18 .. B 0.0
/31.3 2
/3 GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl..

7f83[2] F OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[19 .. B 0.0
/31.3 3
/3 GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl..

7f83[1] I OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. B 33.3
/31.3 6
/6 GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl..

7jni[1] H OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. A 20.0
/34.3 5
/9 C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece..

7vod[13] E OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[12 .. A 50.0
/28.1 10
/10 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7wc7[3] I OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. A 0.0
/28.1 1
/1 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

7wc8[2] I OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. A 0.0
/28.0 4
/4 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

7wc8[1] P OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[13 .. A 50.0
/28.0 6
/6 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

7wc8[1] Q OLC
(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[25 .. A 0.0
/28.0 3
/4 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

4djh[6] H PEG
DI(HYDROXYETHYL)ETHER[7 atoms] B 50.0
/27.5 2
/3 OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme

4djh[2] I PEG
DI(HYDROXYETHYL)ETHER[7 atoms] B 25.0
/27.5 4
/6 OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme

4ib4[2] K PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/27.9 2
/6 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

4ib4[5] L PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/27.9 1
/1 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

5tvn[2] E PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/28.5 2
/6 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

6hlp[1] FA PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/25.3 3
/3 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6hlp[1] HA PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/25.3 2
/2 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6hlp[1] IA PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/25.3 1
/1 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6hlp[1] LA PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/25.3 2
/2 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6hlp[1] R PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 20.0
/25.3 5
/5 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6hlp[1] T PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/25.3 2
/2 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6hlp[1] U PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/25.3 2
/2 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6hlp[1] X PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/25.3 2
/2 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,Substance-P receptor

6wgt[3] H PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 16.7
/26.1 6
/6 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wgt[2] O PEG
DI(HYDROXYETHYL)ETHER[7 atoms] C 0.0
/24.1 2
/2 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7br3[1] E PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 50.0
/29.5 2
/2 GNRHR_HUMAN Q9V2J8_PYRAB GNRHR_HUMAN Gonadotropin-releasing hormone receptor,GlgA glyco..

7br3[1] F PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 50.0
/29.5 2
/2 GNRHR_HUMAN Q9V2J8_PYRAB GNRHR_HUMAN Gonadotropin-releasing hormone receptor,GlgA glyco..

7br3[1] G PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 25.0
/29.5 4
/4 GNRHR_HUMAN Q9V2J8_PYRAB GNRHR_HUMAN Gonadotropin-releasing hormone receptor,GlgA glyco..

7br3[1] I PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 0.0
/29.5 3
/3 GNRHR_HUMAN Q9V2J8_PYRAB GNRHR_HUMAN Gonadotropin-releasing hormone receptor,GlgA glyco..

7br3[1] J PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 100.0
/29.5 1
/3 GNRHR_HUMAN Q9V2J8_PYRAB GNRHR_HUMAN Gonadotropin-releasing hormone receptor,GlgA glyco..

7wc6[5] L PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 25.0
/28.1 4
/4 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7wc7[1] K PEG
DI(HYDROXYETHYL)ETHER[7 atoms] A 25.0
/28.1 4
/4 5HT2A_HUMAN 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,5-hydroxytryptamin..

4dkl[4] R 1PE
PENTAETHYLENE GLYCOL[16 atoms] A 100.0
/29.2 1
/6 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

5wqc[2] H 1PE
PENTAETHYLENE GLYCOL[13 atoms] A 40.0
/27.1 5
/5 OX2R_HUMAN Q9V2J8_PYRAB OX2R_HUMAN Orexin receptor type 2,GlgA glycogen synthase,Orex..

6a93[1] F 1PE
PENTAETHYLENE GLYCOL[13 atoms] A 50.0
/27.6 6
/6 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6a93[2] G 1PE
PENTAETHYLENE GLYCOL[16 atoms] A 40.0
/27.6 5
/8 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

6wgt[2] Q 1PE
PENTAETHYLENE GLYCOL[16 atoms] C 57.1
/24.1 7
/7 5HT2A_HUMAN C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7voe[7] C 1PE
PENTAETHYLENE GLYCOL[16 atoms] A 0.0
/28.2 2
/6 5HT2A_HUMAN C562_ECOLX C562_ECOLX 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A,Soluble cytochrome..

7xn9[1] B EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. A 100.0
/28.0 2
/8 SSR2_HUMAN XYNA_NIACI SSR2_HUMAN Somatostatin receptor type 2,Endo-1,4-beta-xylanas..

4ea3[1] D OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. A 42.9
/30.9 7
/7 C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro..

4ib4[1] F OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[15 .. A 50.0
/27.9 2
/2 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

4ib4[1] H OLB
(2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate[16 .. A 33.3
/27.9 3
/4 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

4nc3[1] J TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms] A 0.0
/27.6 1
/1 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

4nc3[1] N DGA
DIACYL GLYCEROL[26 atoms] A 50.0
/27.6 4
/4 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

4nc3[1] O DGA
DIACYL GLYCEROL[20 atoms] A 25.0
/27.6 4
/4 5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN Chimera protein of human 5-hydroxytryptamine recep..

3pqr[8] J SO4
SULFATE ION[5 atoms] A 0.0
/21.0 4
/4 OPSD_BOVIN Rhodopsin

4dkl[2] C SO4
SULFATE ION[5 atoms] A 20.0
/29.2 5
/6 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

4dkl[2] D SO4
SULFATE ION[5 atoms] A 0.0
/29.2 4
/4 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

4dkl[20] E SO4
SULFATE ION[5 atoms] A 50.0
/29.2 4
/7 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

4dkl[2] G SO4
SULFATE ION[5 atoms] A 66.7
/29.2 3
/4 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

4dkl[2] N SO4
SULFATE ION[5 atoms] A 0.0
/29.2 3
/3 OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera

5t1a[1] D SO4
SULFATE ION[5 atoms] A 0.0
/27.5 1
/4 CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is..

6nwe[1] J SO4
SULFATE ION[5 atoms] A 25.0
/21.0 4
/4 OPSD_BOVIN Rhodopsin

6tod[9] D SO4
SULFATE ION[5 atoms] A 0.0
/28.6 1
/4 OX1R_HUMAN Orexin receptor type 1

6tp3[5] E SO4
SULFATE ION[5 atoms] A 0.0
/28.2 1
/4 OX1R_HUMAN Orexin receptor type 1

7bvq[2] F SO4
SULFATE ION[5 atoms] A 100.0
/26.4 1
/6 D9IEF7_BPT4 Endolysin,Beta-1 adrenergic receptor chimera

7bvq[1] K SO4
SULFATE ION[5 atoms] A 0.0
/26.4 2
/2 D9IEF7_BPT4 Endolysin,Beta-1 adrenergic receptor chimera

4lde[4] E 1WV
(2S)-2,3-dihydroxypropyl (7Z)-tetradec-7-enoate[15.. A 0.0
/25.1 6
/6 LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor

7bvq[2] L 1WV
(2S)-2,3-dihydroxypropyl (7Z)-tetradec-7-enoate[15.. A 0.0
/26.4 4
/6 D9IEF7_BPT4 Endolysin,Beta-1 adrenergic receptor chimera

6hlo[2] C CIT
CITRIC ACID[13 atoms] A 0.0
/25.3 3
/3 NK1R_HUMAN Q9V2J8_PYRAB NK1R_HUMAN Substance-P receptor,GlgA glycogen synthase,Substa..

6to7[2] E CIT
CITRIC ACID[13 atoms] A 16.7
/29.0 6
/6 OX1R_HUMAN Orexin receptor type 1

6tos[1] E CIT
CITRIC ACID[13 atoms] A 33.3
/29.4 6
/8 OX1R_HUMAN Orexin receptor type 1

6tos[1] F CIT
CITRIC ACID[13 atoms] A 20.0
/29.4 5
/6 OX1R_HUMAN Orexin receptor type 1

7bvq[1] N CIT
CITRIC ACID[13 atoms] A 33.3
/26.4 6
/6 D9IEF7_BPT4 Endolysin,Beta-1 adrenergic receptor chimera

7bvq[1] O CIT
CITRIC ACID[13 atoms] A 0.0
/26.4 2
/6 D9IEF7_BPT4 Endolysin,Beta-1 adrenergic receptor chimera

3oax[2] Q 4E6
(4E,6E)-hexadeca-1,4,6-triene[16 atoms] A 0.0
/21.3 4
/6 OPSD_BOVIN Rhodopsin

1gzm[5] BA C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[10 atoms] A 0.0
/21.0 1
/1 OPSD_BOVIN RHODOPSIN

1gzm[2] L C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[17 atoms] A 50.0
/21.0 4
/6 OPSD_BOVIN RHODOPSIN

1gzm[2] M C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[15 atoms] A 0.0
/21.0 4
/4 OPSD_BOVIN RHODOPSIN

1gzm[5] N C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[10 atoms] A 33.3
/21.0 3
/3 OPSD_BOVIN RHODOPSIN

1gzm[3] O C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[18 atoms] A 0.0
/21.0 5
/5 OPSD_BOVIN RHODOPSIN

1gzm[2] Q C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[12 atoms] A 0.0
/21.0 1
/1 OPSD_BOVIN RHODOPSIN

1gzm[1] W C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[12 atoms] A 0.0
/21.0 1
/1 OPSD_BOVIN RHODOPSIN

1gzm[1] Q C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[12 atoms] B 0.0
/21.0 1
/1 OPSD_BOVIN RHODOPSIN

3c9l[1] K C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[17 atoms] A 50.0
/21.0 4
/6 OPSD_BOVIN Rhodopsin

3c9l[1] L C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[15 atoms] A 0.0
/21.0 4
/4 OPSD_BOVIN Rhodopsin

3c9l[1] M C8E
(HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE[10 atoms] A 33.3
/21.0 3
/3 OPSD_BOVIN Rhodopsin

1gzm[2] J PEF
DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE[20 atom.. A 28.6
/21.0 7
/7 OPSD_BOVIN RHODOPSIN

3c9l[1] I PEF
DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE[20 atom.. A 28.6
/21.0 7
/7 OPSD_BOVIN Rhodopsin

1gzm[4] K LDA
LAURYL DIMETHYLAMINE-N-OXIDE[16 atoms] A 28.6
/21.0 7
/7 OPSD_BOVIN RHODOPSIN

3dqb[9] F BOG
octyl beta-D-glucopyranoside[20 atoms] A 0.0
/21.0 7
/7 OPSD_BOVIN Rhodopsin

3dqb[15] G BOG
octyl beta-D-glucopyranoside[20 atoms] A 0.0
/21.0 3
/3 OPSD_BOVIN Rhodopsin

3pqr[4] H BOG
octyl beta-D-glucopyranoside[20 atoms] A 0.0
/21.0 2
/5 OPSD_BOVIN Rhodopsin

4j4q[7] E BOG
octyl beta-D-glucopyranoside[20 atoms] A 16.7
/21.0 12
/12 OPSD_BOVIN Rhodopsin

4j4q[2] H BOG
octyl beta-D-glucopyranoside[20 atoms] A 50.0
/21.0 4
/4 OPSD_BOVIN Rhodopsin

6nwe[1] E BOG
octyl beta-D-glucopyranoside[20 atoms] A 0.0
/21.0 4
/4 OPSD_BOVIN Rhodopsin

3pqr[2] L ACT
ACETATE ION[4 atoms] A 33.3
/21.0 3
/3 OPSD_BOVIN Rhodopsin

4j4q[1] K ACT
ACETATE ION[4 atoms] A 0.0
/21.0 6
/6 OPSD_BOVIN Rhodopsin

3.a³:asym_id for the contact molecule. 4.a⁴:asym_id for the template homologue. 5.identity[%]⁵:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon⁶:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.

MONOMER
424
	pdb_id	a¹	identity[%]²	description
	7ryc	B	63.9	OXYR_HUMAN Oxytocin receptor
	8wz2	F	27.8	QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor
	7xrr	A	28.3	OX2R_HUMAN Orexin receptor type 2
	4yay	A	25.6	C562_ECOLX AGTR1_HUMAN Soluble cytochrome b562,Type-1 angiotensin II receptor
	2ped	B	21.3	OPSD_BOVIN Rhodopsin
	1.a¹:asym_id for the homologue. 2.identity[%]²:sequence identity between the query and the homologue.

Contact Molecules for Homologous Proteins

Summary Bars[0.0 %]

UniProt Feature Tables [P47901(V1BR_HUMAN)]